{"gene":"SLC9A3","run_date":"2026-06-10T07:46:35","timeline":{"discoveries":[{"year":1992,"finding":"NHE3 (NHE-3) encodes a Na+/H+ exchanger isoform with 832 amino acids, 10–12 membrane-spanning domains, and a long cytoplasmic tail with putative protein kinase phosphorylation motifs; it is expressed specifically in intestine and kidney.","method":"cDNA cloning, sequencing, Northern blot, ribonuclease protection assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — primary cloning and sequencing with direct tissue expression mapping, foundational paper replicated by multiple subsequent studies","pmids":["1374392"],"is_preprint":false},{"year":1993,"finding":"NHE3 protein localizes to the brush-border (apical) membrane of renal proximal tubule cells, identified as an ~80 kDa polypeptide by isoform-specific antibody on Western blot and immunocytochemistry.","method":"Isoform-specific antibody (Western blot, immunocytochemistry), NHE3-transfected cell controls","journal":"The American journal of physiology","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal localization confirmed by Western and immunocytochemistry, replicated across multiple subsequent studies","pmids":["8238556"],"is_preprint":false},{"year":1993,"finding":"NHE3 functions as an electroneutral Na+/H+ exchanger with low amiloride sensitivity, apparent KNa of ~4.7 mM for extracellular Na+, and positive cooperative activation by intracellular H+ (half-maximal pK ~6.45); K+o does not inhibit NHE3 (unlike NHE1).","method":"Stable transfection in NHE-deficient CHO (AP-1) cells, amiloride-inhibitable 22Na+ influx assay, kinetic analysis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro reconstitution with quantitative kinetics, foundational functional characterization replicated by subsequent studies","pmids":["8393860"],"is_preprint":false},{"year":1995,"finding":"NHE3 is localized to the apical membrane of S1 and S2 proximal convoluted tubules and medullary/cortical thick ascending limbs in rat kidney; cross-linking studies indicate oligomeric forms of the transporter exist.","method":"Polyclonal antisera against cytoplasmic epitopes, Western blot of fractionated membranes, immunohistochemistry, chemical cross-linking","journal":"Kidney international","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (membrane fractionation, cross-linking, immunohistochemistry), replicated across labs","pmids":["8569082"],"is_preprint":false},{"year":1995,"finding":"PKA activation acutely inhibits NHE3 activity (~39% inhibition); this requires the cytoplasmic C-terminal domain of NHE3, and the purified recombinant cytoplasmic domain is phosphorylated by PKA catalytic subunit in vitro on serine residues; cAMP increases NHE3 phosphocontent ~3-fold in cells.","method":"Stable expression in AP-1 fibroblasts, Xenopus oocyte expression with truncation mutants, in vitro PKA phosphorylation of recombinant domain, immunoprecipitation of phospho-NHE3","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro kinase assay with recombinant domain, truncation mutagenesis, confirmed in two cell systems","pmids":["7593604"],"is_preprint":false},{"year":1995,"finding":"NHE-1, NHE-2, and NHE-3 are electroneutral and voltage-independent Na+/H+ exchangers; currents observed in some cell types during exchange are due to a pre-existing H+ conductance, not the exchanger itself.","method":"Whole-cell patch clamp combined with microfluorimetric pH measurement, CHO cells transfected with NHE isoforms, Zn2+ dissociation experiment","journal":"The Journal of general physiology","confidence":"High","confidence_rationale":"Tier 1 / Strong — electrophysiology combined with fluorimetry and pharmacological dissection in multiple cell types","pmids":["7494140"],"is_preprint":false},{"year":1998,"finding":"NHE3 knockout mice (Slc9a3-/-) exhibit reduced HCO3- and fluid absorption in proximal convoluted tubules, a severe intestinal absorptive defect, mild acidosis, reduced blood pressure, and compensatory upregulation of AE1, renin, colonic H+,K+-ATPase, and ENaC; NHE3 is the major absorptive Na+/H+ exchanger in kidney and intestine.","method":"Gene targeting/knockout mouse model, blood chemistry, renal tubule perfusion, intestinal flux measurements","journal":"Nature genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — loss-of-function mouse with multiple defined physiological readouts, widely replicated","pmids":["9662405"],"is_preprint":false},{"year":1998,"finding":"E3KARP (NHERF2) directly binds NHE3 at an internal region in its C-terminal cytoplasmic tail via E3KARP's second PDZ domain plus C-terminal domain; E3KARP also binds the cytoskeletal protein ezrin, suggesting a scaffold linking NHE3 to ezrin and thereby to PKA (type II).","method":"In vitro binding assays (pulldown), co-localization in PS120 fibroblasts, deletion/domain mapping","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Moderate — in vitro binding with domain mapping plus cellular co-localization, confirmed by multiple orthogonal approaches","pmids":["9748260"],"is_preprint":false},{"year":1998,"finding":"PI3-kinase activity is required for recycling of intracellular NHE3 to the cell surface; PI3-K inhibitors (wortmannin, LY294002) reduce NHE3 plasma membrane expression by decreasing the rate of recycling of endosomal NHE3, thereby inhibiting NHE3-mediated H+ extrusion.","method":"PI3-K inhibitors, epitope-tagged NHE3 in AP-1 cells, immunofluorescence microscopy, ELISA-based surface quantification, temperature-block experiments","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Moderate — multiple pharmacological tools, biochemical surface quantification, and temperature controls in a single study","pmids":["9694828"],"is_preprint":false},{"year":1999,"finding":"cAMP inhibition of NHE3 requires PKA (dominant-negative PKA-regulatory subunit abolishes the effect) and involves in vivo phosphorylation of NHE3 at Ser-552 and Ser-605; single or multiple mutations at these serines reduce PKA regulation, though complex mechanisms involving additional serines also contribute.","method":"Dominant-negative PKA expression, site-directed mutagenesis (8 serines mutated), in vitro PKA phosphorylation, tryptic phosphopeptide mapping of in vivo phosphorylated NHE3","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro kinase assay, site-directed mutagenesis, and in vivo phosphopeptide mapping in two cell lines","pmids":["9933588"],"is_preprint":false},{"year":1999,"finding":"NHERF and E3KARP are necessary for cAMP-dependent phosphorylation of NHE3 in vivo; they act as adapters facilitating PKA-mediated phosphorylation of NHE3, but phosphorylation of NHERF itself is not required for this effect.","method":"Co-immunoprecipitation, in vivo phosphorylation assay, dominant-negative NHERF mutant (triple Ser→Ala), 8-Br-cAMP treatment in PS120 fibroblasts","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — co-IP, mutagenesis, and in vivo phosphorylation in the same study, replicated across labs","pmids":["10455146"],"is_preprint":false},{"year":1999,"finding":"PTH acutely inhibits NHE3 in a biphasic manner: early inhibition (5 min) via NHE3 phosphorylation on multiple serines, followed by dynamin-dependent endocytosis that decreases surface NHE3 antigen (detectable at 30 min); blocking endocytic trafficking with dominant-negative dynamin (K44A) abolishes the late but not early inhibition.","method":"Dominant-negative dynamin mutant, surface NHE3 quantification, phosphorylation assay, OKP cell model","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Moderate — genetic dominant-negative tool plus biochemical time-course dissecting two distinct inhibitory phases","pmids":["10866993"],"is_preprint":false},{"year":1999,"finding":"In vivo PTH infusion provokes redistribution of ~25% of NHE3 from apical membranes to intracellular membrane fractions in renal proximal tubule, associated with natriuresis/diuresis; cAMP-PKA signaling is necessary for NHE3 and NaPi2 internalization.","method":"Intravenous PTH infusion in rats, sorbitol density gradient fractionation of renal cortex membranes, immunoblotting","journal":"The American journal of physiology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — in vivo fractionation with pharmacological controls distinguishing cAMP-dependent from cAMP-independent effects","pmids":["10330053"],"is_preprint":false},{"year":1999,"finding":"ETB receptor activation increases NHE3 phosphorylation on multiple threonine and serine residues in OKP cells, with ETB but not ETA receptor specificity; phosphorylation correlates temporally with activation of NHE3 activity.","method":"Stable transfection of ETB vs ETA receptor cDNA in OKP cells, immunoprecipitation, phosphoamino acid analysis, SDS-PAGE mobility shift, alkaline phosphatase treatment","journal":"The American journal of physiology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — receptor-specific phosphorylation confirmed by alkaline phosphatase reversal and phosphoamino acid analysis","pmids":["10199826"],"is_preprint":false},{"year":2000,"finding":"G protein subunit Gsα directly associates with and regulates NHE3 in renal brush-border membrane vesicles independently of cytoplasmic second messengers; D1-like receptor-mediated inhibition of NHE3 is partially reversed by anti-Gsα antibodies, and GTPγS increases Gsα co-immunoprecipitation with NHE3; Gβγ dimers appear to have a stimulatory effect on NHE3.","method":"Brush-border membrane vesicles devoid of cytoplasmic components, anti-G protein antibodies, co-immunoprecipitation, D1 agonist fenoldopam","journal":"American journal of physiology. Regulatory, integrative and comparative physiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP with GTP analog plus antibody interference in isolated membrane vesicles, single lab","pmids":["10749796"],"is_preprint":false},{"year":2001,"finding":"NHERF co-localizes with NHE3 and ezrin specifically in the apical membrane of proximal tubule cells in rat kidney; NHERF2 is absent from proximal tubule but present in collecting duct where it co-localizes with ROMK, indicating isoform-specific compartmentalization.","method":"Isoform-specific antibodies, immunocytochemical analysis of rat kidney sections","journal":"American journal of physiology. Cell physiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct immunolocalization with multiple isoform-specific antibodies, single lab","pmids":["11121391"],"is_preprint":false},{"year":2001,"finding":"Dopamine (DA) acutely decreases surface NHE3 via stimulation of NHE3 endocytosis through clathrin-coated vesicles; this requires GTPase dynamin, involves increased NHE3 binding to adaptor protein AP2, and is dependent on PKA-mediated phosphorylation of NHE3 at Ser-560 and Ser-613.","method":"Surface NHE3 antigen quantification, dominant-negative dynamin, AP2 binding assay, PKA inhibition (pharmacological and genetic), Ser→Ala mutations, renal cell line","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple genetic and pharmacological tools, site-directed mutagenesis, AP2 binding assay all in one study","pmids":["11328806"],"is_preprint":false},{"year":2001,"finding":"Ileal brush-border NHE3 exists in three pools: ~50% Triton X-100 soluble, ~50% detergent-insoluble, of which ~33% resides in cholesterol-enriched lipid rafts. EGF and clonidine increase the raft pool of NHE3 in the brush border, associated with increased NHE3 activity; lipid rafts and actin cytoskeleton regulate NHE3 basal endocytosis.","method":"Detergent extraction, density gradient fractionation (OptiPrep), EEA1-immunoisolated early endosomes, cholesterol depletion with MβCD, cytochalasin D","journal":"The Journal of physiology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — multiple biochemical fractionation and perturbation approaches in native intestinal tissue and cells","pmids":["11731584"],"is_preprint":false},{"year":2001,"finding":"NHE3 is activated downstream of SGLT1-mediated Na+-glucose cotransport in intestinal epithelial cells, causing NHE3-dependent cytoplasmic alkalinization that requires p38 MAP kinase activity; p38 MAP kinase activation also occurs with Na+-glucose cotransport and is sufficient to trigger NHE3-dependent alkalinization when activated alone.","method":"pH-sensitive dye (BCECF), NHE3-preferential inhibitor S-3226, p38 MAP kinase inhibitors (PD-169316, SB-202190), anisomycin activation, Caco-2 cell monolayers","journal":"American journal of physiology. Cell physiology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — pharmacological dissection with isoform-selective inhibitor and kinase inhibitors, reciprocal activation experiment","pmids":["11600416"],"is_preprint":false},{"year":2002,"finding":"Ca2+-dependent inhibition of NHE3 requires E3KARP (not NHERF), and depends on Ca2+-dependent association of α-actinin-4 with E3KARP (via α-actinin-4's actin-binding plus spectrin repeat domain), forming an NHE3–E3KARP–α-actinin-4 complex; elevated Ca2+ causes NHE3 oligomerization and endocytosis, inhibiting activity.","method":"PS120 fibroblasts stably expressing E3KARP or NHERF, co-immunoprecipitation, dominant-negative α-actinin-4 fragment, ionomycin treatment, NHE3 activity assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — co-IP with domain mapping, dominant-negative construct, and functional rescue experiments","pmids":["11948184"],"is_preprint":false},{"year":2002,"finding":"NHE3 supports receptor-mediated, clathrin-dependent endocytosis (RME) in proximal tubule cells by maintaining endosomal pH homeostasis and endocytic fusion; NHE3 confers cAMP sensitivity to RME, and NHE3 deficiency abolishes cAMP effects on endosomal pH and RME.","method":"Cellular knockout/retransfection in OKP cells, albumin uptake assay, endosomal pH measurement, cAMP treatment","journal":"American journal of physiology. Renal physiology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — knockout/retransfection rescue design with mechanistic readout (endosomal pH and RME)","pmids":["12167607"],"is_preprint":false},{"year":2004,"finding":"Ezrin phosphorylation at Thr567 is required for NHE3 recruitment to the apical membrane after Na+-glucose cotransport; this occurs downstream of p38 MAP kinase, and a dominant-negative N-terminal ezrin construct blocks NHE3 membrane recruitment and cytoplasmic alkalinization without affecting p38 activation.","method":"Dominant-negative ezrin construct, phospho-specific antibody for Thr567, p38 MAP kinase inhibitors, cell surface NHE3 quantification, intestinal epithelial cells","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — dominant-negative genetics, phospho-site antibody, pathway epistasis, multiple orthogonal methods","pmids":["15197272"],"is_preprint":false},{"year":2004,"finding":"Akt2 phosphorylates ezrin at Thr567 in vitro and in cells downstream of PI3-kinase and p38 MAP kinase; Akt2-specific siRNA knockdown prevents ezrin phosphorylation, NHE3 translocation, and NHE3 activation after Na+-glucose cotransport.","method":"In vitro Akt kinase assay with recombinant ezrin, Akt2-specific siRNA, PI3-K inhibitors, Akt inhibitors, NHE3 surface translocation assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro reconstitution of Akt2 phosphorylation of ezrin combined with specific siRNA knockdown and functional NHE3 readout","pmids":["15531580"],"is_preprint":false},{"year":2004,"finding":"Carbachol inhibits ileal NHE3 activity by stimulating NHE3 endocytosis from the brush border (detergent-soluble fraction) into early endosomes; carbachol increases the size of NHE3-containing complexes (specifically in detergent-resistant fraction), enhancing co-immunoprecipitation of NHERF2, α-actinin-4, and PKC with NHE3; this inhibition is fully abolished by Src family kinase inhibitor PP2.","method":"OptiPrep gradient centrifugation, sucrose gradient centrifugation for complex size, co-immunoprecipitation, surface biotinylation, PP2 Src inhibitor, ileal preparations","journal":"The Journal of physiology","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (trafficking, complex formation, co-IP, pharmacological inhibition) in native intestinal tissue","pmids":["14978207"],"is_preprint":false},{"year":2005,"finding":"Glucocorticoid (dexamethasone) activation of NHE3 requires SGK1-mediated phosphorylation of NHE3 at Ser663; in vitro SGK1 kinase assay confirms phosphorylation at Ser663; S663A mutation blocks dexamethasone effect; phosphorylation precedes increased NHE3 activity and is associated with increased surface NHE3 expression.","method":"In vitro SGK1 kinase assay, site-directed mutagenesis (S663A), surface biotinylation, pH-sensitive dye NHE3 activity assay","journal":"American journal of physiology. Cell physiology","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro kinase assay plus mutagenesis plus surface expression assay identifying a specific phosphorylation site","pmids":["15888551"],"is_preprint":false},{"year":2005,"finding":"NHERF2 (but not NHERF1) acts as a cGMP-dependent protein kinase G (cGKII) anchoring protein; cGKII must be membrane-anchored via its myristoyl group and bound to NHERF2 to inhibit NHE3; NHERF2 PDZ2 C-terminus binds both NHE3 and cGKII, enabling cGMP inhibition of NHE3.","method":"PS120 cell co-expression system, in vitro NHERF-cGKII binding assay, non-myristoylated cGKII mutant, NHE3 activity assay, cAMP/cGMP analog pharmacology","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — in vitro binding with mutational analysis (myristoylation mutant) plus cell-based functional assay","pmids":["15722341"],"is_preprint":false},{"year":2005,"finding":"Glucocorticoids acutely increase surface NHE3 via stimulation of NHE3 exocytosis (insertion), without changes in total NHE3 protein or NHE3 endocytosis; this effect does not require new protein synthesis.","method":"Surface biotinylation, biotinylatable NHE3 insertion assay (sulfo-NHS-acetate blockade), MesNa cleavage endocytosis assay, cycloheximide treatment in OKP cells","journal":"American journal of physiology. Renal physiology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal trafficking assays (insertion vs. endocytosis) with protein synthesis inhibitor control","pmids":["15942046"],"is_preprint":false},{"year":2006,"finding":"EPAC (exchange protein directly activated by cAMP) provides a second, PKA-independent pathway for cAMP inhibition of NHE3 activity; EPAC activation inhibits NHE3 without inducing phosphorylation of NHE3 at serines 552/605 and without redistribution of NHE3 from brush-border membrane.","method":"cAMP analogs selective for PKA vs. EPAC, PKA activity assay, H89 inhibitor, NHE3 phosphorylation assay, surface NHE3 quantification in OK cells and murine kidney slices","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Moderate — selective pharmacological tools with biochemical read-outs distinguishing two distinct cAMP effector pathways","pmids":["16407144"],"is_preprint":false},{"year":2006,"finding":"TNF causes NHE3 internalization from the intestinal brush border via PKCα activation, leading to Na+ malabsorption; PKCα inhibition (pharmacological or genetic) prevents NHE3 internalization and diarrhea despite continued barrier dysfunction, demonstrating that coordinated NHE3 inhibition and barrier dysfunction are both required for TNF-mediated diarrhea.","method":"In vivo T cell activation mouse model, surface NHE3 quantification, pharmacological and genetic PKCα inhibition, Na+ absorption measurement","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo genetic and pharmacological epistasis with specific molecular and physiological readouts","pmids":["17016558"],"is_preprint":false},{"year":2006,"finding":"Aldosterone inhibits apical NHE3 and HCO3- absorption in the medullary thick ascending limb (MTAL) through a rapid, nongenomic ERK-dependent pathway; aldosterone activates ERK within 5 min, and MEK/ERK inhibitors (U-0126, PD-98059) prevent both ERK activation and NHE3 inhibition; spironolactone and actinomycin D do not block this effect.","method":"In vitro perfused rat MTALs, HCO3- flux measurement, ERK immune-complex kinase assay, MEK/ERK inhibitors, spironolactone, actinomycin D","journal":"American journal of physiology. Renal physiology","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct tubule perfusion, kinase activity assay, and multiple pharmacological controls distinguishing genomic from nongenomic pathway","pmids":["16757729"],"is_preprint":false},{"year":2007,"finding":"NHE3 phosphorylation at Ser552 and Ser605 by PKA is dissociated from changes in NHE3 transport activity; dramatic phosphorylation at these sites occurs without altered NHE3 activity in vivo (PTH-infused rats) and precedes transport inhibition in vitro, indicating these phosphorylations do not directly inhibit NHE3.","method":"PTH infusion in Sprague-Dawley rats, phosphospecific monoclonal antibodies to pSer552 and pSer605, microvillar membrane vesicle NHE3 activity assay, 22Na uptake in OKP cells","journal":"American journal of physiology. Renal physiology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — phosphospecific antibodies combined with functional transport assay both in vivo and in vitro, single lab","pmids":["17409282"],"is_preprint":false},{"year":2007,"finding":"Synaptotagmin I (Syt I) binds NHE3, co-immunoprecipitates with NHE3 preferentially after cAMP or Ca2+ elevation, and is required for cAMP- and Ca2+-induced NHE3 endocytosis; Syt I siRNA blocks NHE3 endocytosis without preventing NHE3 activity inhibition; Syt I interaction with NHE3 precedes and is required for recruitment of AP2 and clathrin.","method":"Co-immunoprecipitation, siRNA of Syt I/AP2/clathrin, 22Na influx, apical membrane biotin labeling, confocal microscopy in Caco-2BBe cells and mouse jejunum","journal":"American journal of physiology. Gastrointestinal and liver physiology","confidence":"High","confidence_rationale":"Tier 2 / Strong — siRNA knockdown, co-IP, and functional endocytosis/activity assays with multiple components knocked down","pmids":["17307723"],"is_preprint":false},{"year":2008,"finding":"NHE3's C-terminal domain directly binds ezrin via a positively charged juxtamembrane cluster (K516, R520, R527) interacting with the FERM domain III of ezrin; this direct NHE3–ezrin binding is necessary for basal exocytosis, delivery from synthetic pathway, and brush border movement of NHE3.","method":"In vitro binding assays with domain deletions and point mutants, biochemical fractionation, surface NHE3 quantification","journal":"Clinical and experimental pharmacology & physiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct binding with site mutagenesis, review article citing original data, single lab","pmids":["18430067"],"is_preprint":false},{"year":2008,"finding":"IRBIT (IP3 receptor-binding protein released with IP3) binds the C-terminal domain of NHE3 and mediates Ca2+-dependent activation of NHE3 via exocytic trafficking to the plasma membrane; this activation requires calmodulin and CaM-dependent kinase II, and IRBIT can reverse NHERF2-dependent Ca2+-inhibition of NHE3.","method":"Co-immunoprecipitation, siRNA knockdown of IRBIT, exocytosis assay, calmodulin inhibitor, CaM kinase II inhibitor, NHE3 activity assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — co-IP, siRNA knockdown, pharmacological pathway dissection, and trafficking assay in a single study","pmids":["18829453"],"is_preprint":false},{"year":2008,"finding":"Casein kinase 2 (CK2) binds to the NHE3 C-terminal domain (aa 590–667) and phosphorylates a separate site, Ser719, to stimulate basal NHE3 activity; S719A mutation reduces NHE3 surface expression by decreasing exocytosis and plasma membrane delivery; CK2 inhibitor DMAT inhibits NHE3 carrying S719 but not S719A mutant.","method":"LC-MS/MS identification of phosphorylation site, in vitro CK2 kinase assay, S719A/S719D mutagenesis, surface biotinylation, exocytosis assay, CK2 inhibitor DMAT, co-immunoprecipitation","journal":"Molecular biology of the cell","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro kinase assay, mass spectrometry site identification, mutagenesis, surface trafficking assay, and pharmacological confirmation","pmids":["18614797"],"is_preprint":false},{"year":2011,"finding":"SGK3, localized to recycling endosomes (via its Arg90-dependent PX domain), acutely activates NHE3 within 15 min of glucocorticoid treatment in a PI3K- and PDK1-dependent manner; PDK1 translocates to endosomes upon dexamethasone treatment; mutation of SGK3 Arg90 disrupts endosomal localization and delays NHE3 activation.","method":"Transfection of SGK isoforms in PS120 and Caco-2bbe cells, immunofluorescence colocalization, R90A point mutation, PI3K and PDK1 inhibitors, NHE3 activity assay, SGK1/NHERF2 knockout mouse comparison","journal":"Molecular biology of the cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple SGK isoforms, point mutagenesis, knockout mouse comparison, subcellular localization with functional consequence","pmids":["21865597"],"is_preprint":false},{"year":2014,"finding":"cGKII inhibits NHE3 by phosphorylating it at three required sites (rabbit Ser554, Ser607, Ser663; mouse Ser552, Ser605, Ser659); all three phosphorylations must be present simultaneously for cGMP inhibition; cGMP/cGKII reduces surface NHE3. Additionally, Ser663 phosphorylation by dexamethasone is required for glucocorticoid stimulation of NHE3 activity and surface expression.","method":"iTRAQ/LC-MS/MS with TiO2 enrichment, phosphospecific antibodies, site-directed mutagenesis, surface biotinylation, NHE3 activity assay in PS120/NHERF2, Caco-2bbe, and mouse ileum","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — mass spectrometry site identification, mutagenesis, phosphospecific antibody validation, multiple cell systems and native tissue","pmids":["25480791"],"is_preprint":false},{"year":2015,"finding":"Loss-of-function SLC9A3 missense mutations (in the N-terminal transport domain and membrane-spanning regions) cause congenital sodium diarrhea; functionally, these mutations reduce NHE3 activity by decreasing basal surface expression and/or abolishing basal transport function of NHE3 in plasma membrane NHE null fibroblasts, while acute regulation remains normal.","method":"Whole-exome sequencing, Sanger sequencing, functional expression of mutants in NHE null fibroblasts, Na+/H+ exchange activity assay, surface expression assay","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — human disease mutations functionally validated in cell reconstitution system, multiple independent families","pmids":["26358773"],"is_preprint":false},{"year":2015,"finding":"NHE3 and scaffold proteins NHERF1, IRBIT, and ezrin form macrocomplexes in the intestinal brush border; in streptozotocin-diabetic mice these macrocomplexes are disrupted, reducing NHE3 activity; insulin restores the macrocomplexes and NHE3 surface expression. IRBIT facilitates NHE3–NHERF1 interaction via protein kinase D2-dependent phosphorylation, and insulin-stimulated ezrin phosphorylation enhances ezrin–NHERF1–IRBIT–NHE3 interactions.","method":"Co-immunoprecipitation, diabetic mouse model, insulin treatment, NHERF1/IRBIT siRNA knockdown, NHE3 trafficking assay, PKD2 knockdown","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 2 / Strong — co-IP of multiprotein complex, siRNA dissection of components, in vivo diabetic model, and functional NHE3 activity readout","pmids":["26258413"],"is_preprint":false},{"year":2020,"finding":"Tubule-specific NHE3 knockout mice do not respond to empagliflozin (SGLT2 inhibitor) with increased urinary Na+ and bicarbonate excretion or urine pH change, demonstrating that renal NHE3 is required for the natriuretic effect of empagliflozin; empagliflozin in diabetic mice increases NHE3 phosphorylation at S552/S605 (linked to reduced NHE3-mediated reabsorption).","method":"Tubule-specific NHE3 knockout mouse (Pax8-Cre), acute empagliflozin dosing, urine electrolyte/pH measurement, phosphospecific NHE3 antibodies","journal":"American journal of physiology. Renal physiology","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional knockout with pharmacological challenge providing genetic epistasis, in vivo phosphorylation data","pmids":["32893663"],"is_preprint":false},{"year":2020,"finding":"Inducible intestinal epithelial cell-specific NHE3 knockout mice develop watery alkaline diarrhea, metabolic acidosis, hyponatremia, hyperkalemia, and elevated aldosterone, demonstrating that intestinal NHE3 is essential for Na+, acid-base, and volume homeostasis.","method":"Tamoxifen-inducible intestinal epithelial NHE3 knockout (Villin-CreERT2), blood chemistry, urinary and fecal measurements","journal":"Clinical science (London, England : 1979)","confidence":"High","confidence_rationale":"Tier 2 / Strong — tissue-specific conditional knockout with comprehensive metabolic phenotyping","pmids":["32227118"],"is_preprint":false},{"year":1996,"finding":"ETB receptor (but not ETA) activation increases Na+/H+ antiporter (NHE3) activity in OKP cells via Ca2+/calmodulin kinase pathway (~50%) and tyrosine kinase pathway (~50%); Ca2+ elevation alone (through ETA) is not sufficient for activation.","method":"Stable ETB and ETA receptor transfection in OKP cells, BAPTA Ca2+ clamping, KN62 (CaM kinase inhibitor), pertussis toxin, PKC/PLA2/COX inhibitors","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 2 / Strong — receptor-specific transfection, multiple pharmacological pathway dissection, Ca2+ clamping","pmids":["8617878"],"is_preprint":false},{"year":1996,"finding":"ETB receptor-induced NHE3 activation is 50% mediated by tyrosine kinase pathways, involving p210 (integral membrane protein); ET-1 causes tyrosine phosphorylation of focal adhesion proteins (paxillin, p125FAK) via ETB, but these are not required for Na+/H+ antiporter activation.","method":"Cytochalasin D disruption of focal adhesions, immunoprecipitation identifying paxillin and p125FAK, tyrosine phosphorylation assay","journal":"The American journal of physiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — immunoprecipitation identifies specific phosphoproteins; focal adhesion disruption dissects pathway, single lab","pmids":["8843705"],"is_preprint":false},{"year":2002,"finding":"c-Src and ERK are both required for acid-induced activation of NHE3 in renal proximal tubule cells; dominant-negative c-Src (K295M) prevents NHE3 activation and acidosis activates both c-Src and ERK/MEK (but not JNK) independently; MEK inhibition (PD98059) also blocks NHE3 activation by acid.","method":"Dominant-negative c-Src transfection, immune complex kinase assays (enolase, MBP, GST-c-Jun substrates), MEK inhibitor PD98059, in vivo renal cortical kinase activation","journal":"Kidney international","confidence":"High","confidence_rationale":"Tier 2 / Strong — dominant-negative genetics combined with kinase assays and in vivo pathway confirmation","pmids":["12081562"],"is_preprint":false},{"year":2007,"finding":"PDZK1 (NHERF3) is required for cAMP- and Ca2+-mediated inhibition of NHE3 in native colonic enterocytes but not for NHE3 abundance, apical targeting, or hyperosmolarity-induced inhibition; pdzk1-/- mice show drastically reduced acid-activated NHE3 activity and abolished responses to forskolin and ionomycin.","method":"pdzk1 knockout mice, fluorometric NHE3 activity assay in isolated colonic crypts, Western blot, immunohistochemistry, selective NHE3 inhibitor S1611","journal":"The Journal of physiology","confidence":"High","confidence_rationale":"Tier 2 / Strong — knockout mouse combined with fluorometric functional assay, selective inhibitor controls, and protein expression analysis","pmids":["17395628"],"is_preprint":false},{"year":2017,"finding":"Loss of SLC9A3 in mice dramatically decreases CFTR protein expression in the epididymis and vas deferens, leading to obstructive azoospermia with abnormal secretions, calcification, and disorganized stereocilia in the male reproductive tract.","method":"Slc9a3 knockout mice, immunoblotting of CFTR, immunohistochemistry, ultrastructural analysis (electron microscopy)","journal":"PLoS genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — knockout model with multiple orthogonal methods (immunoblot, IHC, EM), clear molecular and structural phenotype","pmids":["28384194"],"is_preprint":false}],"current_model":"SLC9A3/NHE3 is an electroneutral, voltage-independent Na+/H+ antiporter localized to the apical (brush-border) membrane of renal proximal tubule and intestinal epithelial cells, where it mediates the bulk of NaCl, NaHCO3, and fluid absorption; its activity is acutely regulated by dynamic endocytic recycling (controlled by PI3-kinase) and by a multiprotein signaling scaffold—comprising NHERF1/NHERF2 (E3KARP), ezrin, and IRBIT—that anchors PKA, PKG (cGKII), and SGK isoforms in the vicinity of NHE3's cytoplasmic tail, enabling phosphorylation at specific serines (Ser552, Ser605, Ser663, Ser719) to modulate transporter surface expression (exocytosis/endocytosis) and intrinsic activity in response to cAMP, cGMP, Ca2+, glucocorticoids, PTH, dopamine, endothelin, TNF, and other hormones."},"narrative":{"mechanistic_narrative":"SLC9A3/NHE3 is the principal apical Na+/H+ exchanger of renal proximal tubule and intestinal brush-border epithelia, where it drives the bulk of transepithelial Na+, HCO3-, and fluid absorption [PMID:1374392, PMID:9662405, PMID:32227118]. It operates as an electroneutral, voltage-independent antiporter with low amiloride sensitivity, an extracellular Na+ affinity near 4.7 mM, and cooperative activation by intracellular H+ [PMID:8393860, PMID:7494140]. Genetic ablation establishes its physiological centrality: whole-body and tissue-specific knockouts produce defective renal HCO3-/fluid reabsorption, severe intestinal Na+ malabsorption, watery alkaline diarrhea, acidosis, and disturbed volume homeostasis [PMID:9662405, PMID:32227118], and loss-of-function missense mutations in its N-terminal transport domain cause congenital sodium diarrhea by reducing basal surface expression and transport [PMID:26358773]. NHE3 activity is governed by dynamic endocytic recycling, with PI3-kinase required for return of intracellular transporter to the surface and dynamin-/clathrin/AP2-dependent internalization removing it [PMID:9694828, PMID:10866993, PMID:11328806]. This trafficking is organized by a C-terminal scaffold: NHE3 binds directly to ezrin through a juxtamembrane basic cluster and to the PDZ proteins NHERF1/NHERF2(E3KARP) and PDZK1(NHERF3), assembling macrocomplexes that also recruit IRBIT, alpha-actinin-4, and anchored kinases (PKA, cGKII) to position signaling enzymes near the cytoplasmic tail [PMID:9748260, PMID:11948184, PMID:15722341, PMID:18430067, PMID:26258413, PMID:17395628]. Hormonal and metabolic inputs converge on phosphorylation of defined serines that bidirectionally tune surface abundance and intrinsic activity: PKA (Ser552/Ser605), cGKII (multi-site, inhibitory), SGK1 and CK2 (Ser663, Ser719; stimulatory), acting downstream of cAMP, cGMP, glucocorticoids, PTH, dopamine, endothelin, TNF, and Na+-glucose cotransport [PMID:7593604, PMID:9933588, PMID:15888551, PMID:15722341, PMID:18614797, PMID:25480791]. Notably, PKA phosphorylation at Ser552/Ser605 can be dissociated from transport changes, and a PKA-independent EPAC arm also mediates cAMP inhibition [PMID:16407144, PMID:17409282].","teleology":[{"year":1992,"claim":"Establishing that NHE3 is a distinct Na+/H+ exchanger isoform with tissue-restricted expression defined the molecule whose absorptive function the field would dissect.","evidence":"cDNA cloning, sequencing, and Northern/RNase protection mapping to intestine and kidney","pmids":["1374392"],"confidence":"High","gaps":["Sequence alone did not establish transport kinetics or membrane topology in situ","Subcellular localization not yet defined"]},{"year":1993,"claim":"Localizing NHE3 to the apical brush-border membrane and characterizing its electroneutral kinetics tied the cloned isoform to vectorial epithelial Na+ absorption.","evidence":"Isoform-specific antibody immunocytochemistry/Western blot, and 22Na+ influx kinetics in NHE-deficient CHO cells","pmids":["8238556","8393860"],"confidence":"High","gaps":["Did not address acute hormonal regulation","Oligomeric/quaternary state not resolved"]},{"year":1995,"claim":"Demonstrating PKA-dependent phosphorylation of the NHE3 C-terminal tail with functional inhibition opened the mechanism of acute hormonal control.","evidence":"In vitro PKA phosphorylation of recombinant cytoplasmic domain, truncation mutagenesis in oocytes and fibroblasts","pmids":["7593604","7494140"],"confidence":"High","gaps":["Specific regulatory serines not yet identified","Link between phosphorylation and trafficking unestablished"]},{"year":1998,"claim":"Knockout mice and the discovery of PI3-kinase-dependent recycling and NHERF2/ezrin scaffolding showed NHE3 is the dominant absorptive exchanger and is regulated by both trafficking and a C-terminal protein complex.","evidence":"Slc9a3-/- mouse physiology, PI3-K inhibitor surface assays, in vitro NHERF2-NHE3-ezrin binding/co-localization","pmids":["9662405","9694828","9748260"],"confidence":"High","gaps":["Compensatory upregulation complicated interpretation of basal role","How scaffold links to kinase recruitment not yet mechanistic"]},{"year":1999,"claim":"Mapping PKA phosphorylation to Ser552/Ser605 and showing NHERF/E3KARP adapters are required for cAMP-dependent phosphorylation defined the molecular logic of cAMP regulation.","evidence":"Site-directed mutagenesis, phosphopeptide mapping, dominant-negative PKA and NHERF in PS120 fibroblasts","pmids":["9933588","10455146"],"confidence":"High","gaps":["Additional serines contribute but were not fully resolved","Causal link of these specific sites to transport rate left open"]},{"year":1999,"claim":"Dissection of PTH action established a biphasic model: rapid phosphorylation-driven inhibition followed by dynamin-dependent endocytic retrieval of NHE3.","evidence":"Dominant-negative dynamin, surface antigen time-course in OKP cells, in vivo PTH infusion with membrane fractionation","pmids":["10866993","10330053"],"confidence":"High","gaps":["Identity of early intrinsic-inhibition mechanism not defined","Endocytic adaptor machinery not yet identified"]},{"year":2000,"claim":"Direct Gsalpha association with NHE3 in brush-border vesicles indicated regulation that can bypass cytoplasmic second messengers.","evidence":"Co-IP with GTPgammaS and anti-G protein antibodies in membrane vesicles, D1 agonist","pmids":["10749796"],"confidence":"Medium","gaps":["Single-lab membrane-vesicle co-IP without reciprocal validation","Physiological significance of direct G protein binding unclear"]},{"year":2001,"claim":"Defining endocytic and lipid-raft pools and the dopamine/AP2/dynamin internalization pathway connected specific PKA sites to clathrin-mediated retrieval.","evidence":"Surface antigen and AP2 binding assays, Ser560/Ser613 mutagenesis, detergent/raft fractionation in renal and intestinal cells","pmids":["11328806","11731584","11121391"],"confidence":"High","gaps":["Recognition of NHE3 by endocytic machinery not molecularly defined","Raft-dependence mechanism incompletely resolved"]},{"year":2001,"claim":"Identifying the SGLT1->p38 MAPK pathway that activates NHE3 linked nutrient cotransport to coordinate downstream absorptive activation.","evidence":"BCECF pH imaging, NHE3-selective inhibitor S-3226, p38 inhibitors and anisomycin in Caco-2 monolayers","pmids":["11600416"],"confidence":"High","gaps":["Effector linking p38 to NHE3 membrane recruitment not yet identified"]},{"year":2002,"claim":"Showing Ca2+ inhibition requires an E3KARP-alpha-actinin-4 complex and that acid activation requires c-Src/ERK expanded the scaffold and kinase repertoire controlling NHE3.","evidence":"Co-IP and dominant-negative alpha-actinin-4 in PS120 cells; dominant-negative c-Src and MEK inhibitors with renal kinase assays","pmids":["11948184","12081562","12167607"],"confidence":"High","gaps":["How Ca2+ triggers oligomerization mechanistically unresolved","Direct substrate of c-Src/ERK on NHE3 pathway not defined"]},{"year":2004,"claim":"Identifying ezrin Thr567 phosphorylation by Akt2 downstream of p38 as the step recruiting NHE3 to the apical membrane completed the SGLT1-to-trafficking axis.","evidence":"Dominant-negative ezrin, phospho-Thr567 antibody, in vitro Akt2 kinase assay and Akt2 siRNA in intestinal cells","pmids":["15197272","15531580"],"confidence":"High","gaps":["How phospho-ezrin physically delivers NHE3 to surface not visualized","Generalizability beyond glucose-coupled stimulus untested here"]},{"year":2005,"claim":"Resolving distinct stimulatory and inhibitory anchored-kinase modules (SGK1/Ser663 for glucocorticoids; NHERF2-anchored cGKII for cGMP) demonstrated bidirectional, scaffold-localized phosphoregulation.","evidence":"In vitro SGK1 kinase assay with S663A mutant and surface assays; cGKII myristoylation/NHERF2 binding mutants in PS120 cells","pmids":["15888551","15722341","15942046"],"confidence":"High","gaps":["cGKII inhibitory phospho-sites not yet all mapped (resolved later)","Crosstalk between stimulatory and inhibitory modules unquantified"]},{"year":2006,"claim":"Discovery of a PKA-independent EPAC arm and of TNF-PKCalpha-driven brush-border internalization broadened cAMP signaling and connected NHE3 inhibition to inflammatory diarrhea.","evidence":"PKA- vs EPAC-selective cAMP analogs; in vivo T-cell activation model with PKCalpha inhibition; perfused MTAL aldosterone/ERK assays","pmids":["16407144","17016558","16757729"],"confidence":"High","gaps":["EPAC downstream effector on NHE3 not identified","Molecular target of nongenomic aldosterone/ERK on NHE3 unresolved"]},{"year":2007,"claim":"Showing Ser552/Ser605 phosphorylation can be dissociated from activity, identifying synaptotagmin I as an endocytic partner, and PDZK1 as an inhibition-specific scaffold refined the relationship between phosphorylation, trafficking, and function.","evidence":"Phosphospecific antibodies with transport assays in PTH-rats; Syt I/AP2/clathrin siRNA co-IP in Caco-2/jejunum; pdzk1-/- colonic crypt assays; ETB tyrosine-kinase pathway dissection","pmids":["17409282","17307723","17395628","8843705"],"confidence":"High","gaps":["Functional phospho-site(s) directly controlling transport rate still uncertain","How distinct NHERF isoforms specify different responses unresolved"]},{"year":2008,"claim":"Defining the direct NHE3-ezrin binding cluster, the IRBIT-mediated Ca2+/CaMKII exocytic activation, and CK2 phosphorylation of Ser719 detailed the molecular determinants of basal and stimulated surface delivery.","evidence":"Point-mutant binding assays (K516/R520/R527-FERM); IRBIT co-IP/siRNA with CaM/CaMKII inhibitors; LC-MS/MS, CK2 assay, S719A/D mutagenesis","pmids":["18430067","18829453","18614797"],"confidence":"High","gaps":["Structural basis of multivalent scaffold assembly not solved","Integration of competing IRBIT-activation vs E3KARP-inhibition unresolved"]},{"year":2011,"claim":"Localizing SGK3 to recycling endosomes as a PI3K/PDK1-dependent NHE3 activator added a compartment-specific layer to acute glucocorticoid regulation.","evidence":"SGK isoform transfection, PX-domain R90A mutant, PDK1 translocation imaging, knockout mouse comparison","pmids":["21865597"],"confidence":"High","gaps":["Direct SGK3 substrate site on NHE3 not pinpointed","Relative contribution of SGK1 vs SGK3 in vivo unquantified"]},{"year":2014,"claim":"Mapping the three obligate cGKII inhibitory sites and confirming Ser663 as the glucocorticoid stimulatory site established multi-site phospho-codes with opposite functional outcomes.","evidence":"iTRAQ/TiO2 LC-MS/MS, phosphospecific antibodies, mutagenesis, surface/activity assays in PS120/NHERF2, Caco-2, mouse ileum","pmids":["25480791"],"confidence":"High","gaps":["How combinatorial phosphorylation is decoded into trafficking remains mechanistic"]},{"year":2015,"claim":"Linking SLC9A3 loss-of-function mutations to congenital sodium diarrhea and showing insulin-restored macrocomplexes in diabetes connected the molecular model to human disease and metabolic state.","evidence":"Exome sequencing with mutant reconstitution in NHE-null fibroblasts; diabetic mouse co-IP with NHERF1/IRBIT/PKD2 siRNA","pmids":["26358773","26258413"],"confidence":"High","gaps":["Genotype-phenotype severity correlation not fully mapped","In vivo dynamics of macrocomplex assembly not directly observed"]},{"year":2020,"claim":"Conditional tissue-specific knockouts proved renal NHE3 is required for SGLT2-inhibitor natriuresis and that intestinal NHE3 is essential for systemic Na+/acid-base/volume homeostasis.","evidence":"Pax8-Cre and Villin-CreERT2 NHE3 knockouts, empagliflozin challenge, urine/blood chemistry, phosphospecific antibodies","pmids":["32893663","32227118"],"confidence":"High","gaps":["Mechanism linking SGLT2 inhibition to NHE3 phosphorylation not fully defined","Reproductive role mechanism (CFTR dependence) addressed separately"]},{"year":2017,"claim":"Discovery that NHE3 loss reduces CFTR in the male reproductive tract revealed a non-absorptive role coupling NHE3 to epithelial secretion and fertility.","evidence":"Slc9a3 knockout mice, CFTR immunoblot/IHC, electron microscopy of vas deferens/epididymis","pmids":["28384194"],"confidence":"High","gaps":["Mechanism by which NHE3 controls CFTR abundance unresolved","Direct vs indirect coupling not distinguished"]},{"year":null,"claim":"How combinatorial multi-site phosphorylation, competing scaffold assemblies, and endosomal recycling are integrated in real time to set NHE3 surface density remains the central unresolved mechanistic question.","evidence":"","pmids":[],"confidence":"High","gaps":["No structural model of the assembled NHE3-scaffold-kinase macrocomplex","Quantitative decoding of opposing phospho-marks into trafficking outcomes not established","Direct mechanism of NHE3-dependent control of CFTR abundance unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0005215","term_label":"transporter activity","supporting_discovery_ids":[0,2,5,6]},{"term_id":"GO:0140104","term_label":"molecular carrier activity","supporting_discovery_ids":[2,5]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[1,3,15]},{"term_id":"GO:0031410","term_label":"cytoplasmic vesicle","supporting_discovery_ids":[8,17,31]},{"term_id":"GO:0005768","term_label":"endosome","supporting_discovery_ids":[8,17,35]}],"pathway":[{"term_id":"R-HSA-382551","term_label":"Transport of small molecules","supporting_discovery_ids":[2,6,40]},{"term_id":"R-HSA-5653656","term_label":"Vesicle-mediated transport","supporting_discovery_ids":[8,11,16,31]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[9,16,24,25,36]}],"complexes":["NHE3-NHERF1-IRBIT-ezrin brush-border macrocomplex","NHE3-E3KARP(NHERF2)-alpha-actinin-4 complex"],"partners":["NHERF2","NHERF1","PDZK1","EZR","IRBIT","ACTN4","SYT1","PRKACA"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P48764","full_name":"Sodium/hydrogen exchanger 3","aliases":["Na(+)/H(+) exchanger 3","NHE-3","Solute carrier family 9 member 3"],"length_aa":834,"mass_kda":92.9,"function":"Plasma membrane Na(+)/H(+) antiporter (PubMed:18829453, PubMed:26358773, PubMed:35613257). Exchanges intracellular H(+) ions for extracellular Na(+) in 1:1 stoichiometry, playing a key role in salt and fluid absorption and pH homeostasis (By similarity). Major apical Na(+)/H(+) exchanger in kidney and intestine playing an important role in renal and intestine Na(+) absorption and blood pressure regulation (PubMed:24622516, PubMed:26358773)","subcellular_location":"Apical cell membrane; Cell membrane; Recycling endosome membrane; Early endosome membrane","url":"https://www.uniprot.org/uniprotkb/P48764/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/SLC9A3","classification":"Not Classified","n_dependent_lines":28,"n_total_lines":1208,"dependency_fraction":0.023178807947019868},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/SLC9A3","total_profiled":1310},"omim":[{"mim_id":"616868","title":"DIARRHEA 8, SECRETORY SODIUM, CONGENITAL; DIAR8","url":"https://www.omim.org/entry/616868"},{"mim_id":"614589","title":"SKI3 SUBUNIT OF SUPERKILLER COMPLEX; SKIC3","url":"https://www.omim.org/entry/614589"},{"mim_id":"613101","title":"HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 5, WITH OR WITHOUT MICROVILLUS INCLUSION DISEASE; FHL5","url":"https://www.omim.org/entry/613101"},{"mim_id":"612730","title":"SOLUTE CARRIER FAMILY 9 (SODIUM/HYDROGEN EXCHANGER), MEMBER 8; SLC9A8","url":"https://www.omim.org/entry/612730"},{"mim_id":"612720","title":"DExH-BOX HELICASE; DHX29","url":"https://www.omim.org/entry/612720"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Plasma membrane","reliability":"Supported"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"gallbladder","ntpm":42.6},{"tissue":"intestine","ntpm":88.4},{"tissue":"kidney","ntpm":64.4},{"tissue":"stomach 1","ntpm":47.2}],"url":"https://www.proteinatlas.org/search/SLC9A3"},"hgnc":{"alias_symbol":["NHE-3"],"prev_symbol":["NHE3"]},"alphafold":{"accession":"P48764","domains":[{"cath_id":"1.20.1530.20","chopping":"113-342_364-464","consensus_level":"high","plddt":89.0121,"start":113,"end":464},{"cath_id":"-","chopping":"479-549","consensus_level":"medium","plddt":73.877,"start":479,"end":549}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P48764","model_url":"https://alphafold.ebi.ac.uk/files/AF-P48764-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P48764-F1-predicted_aligned_error_v6.png","plddt_mean":65.94},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=SLC9A3","jax_strain_url":"https://www.jax.org/strain/search?query=SLC9A3"},"sequence":{"accession":"P48764","fasta_url":"https://rest.uniprot.org/uniprotkb/P48764.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P48764/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P48764"}},"corpus_meta":[{"pmid":"9662405","id":"PMC_9662405","title":"Renal and intestinal absorptive defects in mice lacking the NHE3 Na+/H+ exchanger.","date":"1998","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/9662405","citation_count":671,"is_preprint":false},{"pmid":"8238556","id":"PMC_8238556","title":"NHE3: a Na+/H+ exchanger isoform of renal brush border.","date":"1993","source":"The American journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/8238556","citation_count":353,"is_preprint":false},{"pmid":"1374392","id":"PMC_1374392","title":"Cloning and sequencing of a rabbit cDNA encoding an intestinal and kidney-specific Na+/H+ exchanger isoform (NHE-3).","date":"1992","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/1374392","citation_count":338,"is_preprint":false},{"pmid":"8569082","id":"PMC_8569082","title":"Expression of NHE-3 in the apical membrane of rat renal proximal tubule and thick ascending limb.","date":"1995","source":"Kidney international","url":"https://pubmed.ncbi.nlm.nih.gov/8569082","citation_count":322,"is_preprint":false},{"pmid":"9748260","id":"PMC_9748260","title":"NHE3 kinase A regulatory protein E3KARP binds the epithelial brush border Na+/H+ exchanger NHE3 and the cytoskeletal protein ezrin.","date":"1998","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9748260","citation_count":244,"is_preprint":false},{"pmid":"8772498","id":"PMC_8772498","title":"NHE2 and NHE3 are human and rabbit intestinal brush-border proteins.","date":"1996","source":"The American journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/8772498","citation_count":243,"is_preprint":false},{"pmid":"8393860","id":"PMC_8393860","title":"Heterologous expression and functional properties of amiloride high affinity (NHE-1) and low affinity (NHE-3) isoforms of the rat Na/H exchanger.","date":"1993","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8393860","citation_count":224,"is_preprint":false},{"pmid":"8282777","id":"PMC_8282777","title":"Na+/H+ exchangers, NHE-1 and NHE-3, of rat intestine. Expression and localization.","date":"1994","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/8282777","citation_count":209,"is_preprint":false},{"pmid":"9792717","id":"PMC_9792717","title":"The role of NHERF and E3KARP in the cAMP-mediated inhibition of NHE3.","date":"1998","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9792717","citation_count":178,"is_preprint":false},{"pmid":"17016558","id":"PMC_17016558","title":"Coordinated epithelial NHE3 inhibition and barrier dysfunction are required for TNF-mediated diarrhea in vivo.","date":"2006","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/17016558","citation_count":168,"is_preprint":false},{"pmid":"32893663","id":"PMC_32893663","title":"A role for tubular Na+/H+ exchanger NHE3 in the natriuretic effect of the SGLT2 inhibitor empagliflozin.","date":"2020","source":"American journal of physiology. Renal physiology","url":"https://pubmed.ncbi.nlm.nih.gov/32893663","citation_count":166,"is_preprint":false},{"pmid":"9694828","id":"PMC_9694828","title":"Endosomal recycling of the Na+/H+ exchanger NHE3 isoform is regulated by the phosphatidylinositol 3-kinase pathway.","date":"1998","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9694828","citation_count":143,"is_preprint":false},{"pmid":"11960774","id":"PMC_11960774","title":"Intestinal NaCl transport in NHE2 and NHE3 knockout mice.","date":"2002","source":"American journal of physiology. Gastrointestinal and liver physiology","url":"https://pubmed.ncbi.nlm.nih.gov/11960774","citation_count":123,"is_preprint":false},{"pmid":"11328806","id":"PMC_11328806","title":"Dopamine acutely stimulates Na+/H+ exchanger (NHE3) endocytosis via clathrin-coated vesicles: dependence on protein kinase A-mediated NHE3 phosphorylation.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11328806","citation_count":123,"is_preprint":false},{"pmid":"9933588","id":"PMC_9933588","title":"Acute inhibition of Na/H exchanger NHE-3 by cAMP. Role of protein kinase a and NHE-3 phosphoserines 552 and 605.","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9933588","citation_count":122,"is_preprint":false},{"pmid":"11121391","id":"PMC_11121391","title":"Differential renal distribution of NHERF isoforms and their colocalization with NHE3, ezrin, and ROMK.","date":"2001","source":"American journal of physiology. Cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/11121391","citation_count":115,"is_preprint":false},{"pmid":"11731584","id":"PMC_11731584","title":"Na+-H+ exchanger 3 (NHE3) is present in lipid rafts in the rabbit ileal brush border: a role for rafts in trafficking and rapid stimulation of NHE3.","date":"2001","source":"The Journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/11731584","citation_count":112,"is_preprint":false},{"pmid":"26358773","id":"PMC_26358773","title":"Reduced sodium/proton exchanger NHE3 activity causes congenital sodium diarrhea.","date":"2015","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/26358773","citation_count":107,"is_preprint":false},{"pmid":"11948184","id":"PMC_11948184","title":"Ca(2+)-dependent inhibition of Na+/H+ exchanger 3 (NHE3) requires an NHE3-E3KARP-alpha-actinin-4 complex for oligomerization and endocytosis.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11948184","citation_count":106,"is_preprint":false},{"pmid":"11287336","id":"PMC_11287336","title":"IFN-gamma downregulates expression of Na(+)/H(+) exchangers NHE2 and NHE3 in rat intestine and human Caco-2/bbe cells.","date":"2001","source":"American journal of physiology. Cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/11287336","citation_count":103,"is_preprint":false},{"pmid":"10966919","id":"PMC_10966919","title":"Signal complex regulation of renal transport proteins: NHERF and regulation of NHE3 by PKA.","date":"2000","source":"American journal of physiology. Renal physiology","url":"https://pubmed.ncbi.nlm.nih.gov/10966919","citation_count":100,"is_preprint":false},{"pmid":"10455146","id":"PMC_10455146","title":"cAMP-induced phosphorylation and inhibition of Na(+)/H(+) exchanger 3 (NHE3) are dependent on the presence but not the phosphorylation of NHE regulatory factor.","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10455146","citation_count":99,"is_preprint":false},{"pmid":"10866993","id":"PMC_10866993","title":"Acute regulation of Na+/H+ exchanger NHE3 by parathyroid hormone via NHE3 phosphorylation and dynamin-dependent endocytosis.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10866993","citation_count":99,"is_preprint":false},{"pmid":"18626081","id":"PMC_18626081","title":"Branchial expression and localization of SLC9A2 and SLC9A3 sodium/hydrogen exchangers and their possible role in acid-base regulation in freshwater rainbow trout (Oncorhynchus mykiss).","date":"2008","source":"The Journal of experimental biology","url":"https://pubmed.ncbi.nlm.nih.gov/18626081","citation_count":95,"is_preprint":false},{"pmid":"7631739","id":"PMC_7631739","title":"Acid incubation increases NHE-3 mRNA abundance in OKP cells.","date":"1995","source":"The American journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/7631739","citation_count":87,"is_preprint":false},{"pmid":"25552580","id":"PMC_25552580","title":"Human Clostridium difficile infection: inhibition of NHE3 and microbiota profile.","date":"2014","source":"American journal of physiology. Gastrointestinal and liver physiology","url":"https://pubmed.ncbi.nlm.nih.gov/25552580","citation_count":86,"is_preprint":false},{"pmid":"16407144","id":"PMC_16407144","title":"Regulation of sodium-proton exchanger isoform 3 (NHE3) by PKA and exchange protein directly activated by cAMP (EPAC).","date":"2006","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/16407144","citation_count":84,"is_preprint":false},{"pmid":"16421216","id":"PMC_16421216","title":"Expression of SLC26A3, CFTR and NHE3 in the human male reproductive tract: role in male subfertility caused by congenital chloride diarrhoea.","date":"2006","source":"Molecular human reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/16421216","citation_count":81,"is_preprint":false},{"pmid":"9011571","id":"PMC_9011571","title":"Chronic metabolic acidosis enhances NHE-3 protein abundance and transport activity in the rat thick ascending limb by increasing NHE-3 mRNA.","date":"1997","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/9011571","citation_count":80,"is_preprint":false},{"pmid":"15722341","id":"PMC_15722341","title":"cGMP inhibition of Na+/H+ antiporter 3 (NHE3) requires PDZ domain adapter NHERF2, a broad specificity protein kinase G-anchoring protein.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15722341","citation_count":80,"is_preprint":false},{"pmid":"15197272","id":"PMC_15197272","title":"Ezrin regulates NHE3 translocation and activation after Na+-glucose cotransport.","date":"2004","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/15197272","citation_count":79,"is_preprint":false},{"pmid":"15531580","id":"PMC_15531580","title":"Akt2 phosphorylates ezrin to trigger NHE3 translocation and activation.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15531580","citation_count":79,"is_preprint":false},{"pmid":"7593604","id":"PMC_7593604","title":"Activation of protein kinase A acutely inhibits and phosphorylates Na/H exchanger NHE-3.","date":"1995","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/7593604","citation_count":78,"is_preprint":false},{"pmid":"10199826","id":"PMC_10199826","title":"ETB receptor activation leads to activation and phosphorylation of NHE3.","date":"1999","source":"The American journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/10199826","citation_count":77,"is_preprint":false},{"pmid":"16648141","id":"PMC_16648141","title":"Na+/H+ exchanger NHE3 activity and trafficking are lipid Raft-dependent.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16648141","citation_count":75,"is_preprint":false},{"pmid":"20011065","id":"PMC_20011065","title":"Mechanisms of the regulation of the intestinal Na+/H+ exchanger NHE3.","date":"2010","source":"Journal of biomedicine & biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/20011065","citation_count":74,"is_preprint":false},{"pmid":"15994375","id":"PMC_15994375","title":"NHE3 in an ancestral vertebrate: primary sequence, distribution, localization, and function in gills.","date":"2005","source":"American journal of physiology. Regulatory, integrative and comparative physiology","url":"https://pubmed.ncbi.nlm.nih.gov/15994375","citation_count":74,"is_preprint":false},{"pmid":"10330053","id":"PMC_10330053","title":"In vivo PTH provokes apical NHE3 and NaPi2 redistribution and Na-K-ATPase inhibition.","date":"1999","source":"The American journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/10330053","citation_count":72,"is_preprint":false},{"pmid":"9435499","id":"PMC_9435499","title":"Functional and molecular characterization of NHE3 expression during ontogeny in rat jejunal epithelium.","date":"1997","source":"The American journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/9435499","citation_count":66,"is_preprint":false},{"pmid":"14962844","id":"PMC_14962844","title":"The Na+/H+ exchanger isoform 2 is the predominant NHE isoform in murine colonic crypts and its lack causes NHE3 upregulation.","date":"2004","source":"American journal of physiology. Gastrointestinal and liver physiology","url":"https://pubmed.ncbi.nlm.nih.gov/14962844","citation_count":66,"is_preprint":false},{"pmid":"8631855","id":"PMC_8631855","title":"Genomic organization and glucocorticoid transcriptional activation of the rat Na+/H+ exchanger Nhe3 gene.","date":"1996","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8631855","citation_count":66,"is_preprint":false},{"pmid":"15942046","id":"PMC_15942046","title":"Glucocorticoids acutely increase cell surface Na+/H+ exchanger-3 (NHE3) by activation of NHE3 exocytosis.","date":"2005","source":"American journal of physiology. Renal physiology","url":"https://pubmed.ncbi.nlm.nih.gov/15942046","citation_count":65,"is_preprint":false},{"pmid":"17409282","id":"PMC_17409282","title":"NHE3 phosphorylation at serines 552 and 605 does not directly affect NHE3 activity.","date":"2007","source":"American journal of physiology. Renal physiology","url":"https://pubmed.ncbi.nlm.nih.gov/17409282","citation_count":64,"is_preprint":false},{"pmid":"10444581","id":"PMC_10444581","title":"Altered expression of Na transporters NHE-3, NaPi-II, Na-K-ATPase, BSC-1, and TSC in CRF rat kidneys.","date":"1999","source":"The American journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/10444581","citation_count":64,"is_preprint":false},{"pmid":"18829453","id":"PMC_18829453","title":"IRBIT, inositol 1,4,5-triphosphate (IP3) receptor-binding protein released with IP3, binds Na+/H+ exchanger NHE3 and activates NHE3 activity in response to calcium.","date":"2008","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18829453","citation_count":63,"is_preprint":false},{"pmid":"8617878","id":"PMC_8617878","title":"Endothelin(B) receptor activates NHE-3 by a Ca2+-dependent pathway in OKP cells.","date":"1996","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/8617878","citation_count":63,"is_preprint":false},{"pmid":"12388387","id":"PMC_12388387","title":"Altered expression of renal NHE3, TSC, BSC-1, and ENaC subunits in potassium-depleted rats.","date":"2002","source":"American journal of physiology. Renal physiology","url":"https://pubmed.ncbi.nlm.nih.gov/12388387","citation_count":62,"is_preprint":false},{"pmid":"15888551","id":"PMC_15888551","title":"Activation of NHE3 by dexamethasone requires phosphorylation of NHE3 at Ser663 by SGK1.","date":"2005","source":"American journal of physiology. Cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/15888551","citation_count":61,"is_preprint":false},{"pmid":"28385297","id":"PMC_28385297","title":"Renal tubular NHE3 is required in the maintenance of water and sodium chloride homeostasis.","date":"2017","source":"Kidney international","url":"https://pubmed.ncbi.nlm.nih.gov/28385297","citation_count":60,"is_preprint":false},{"pmid":"9612213","id":"PMC_9612213","title":"Quantitative contribution of NHE2 and NHE3 to rabbit ileal brush-border Na+/H+ exchange.","date":"1998","source":"The American journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/9612213","citation_count":59,"is_preprint":false},{"pmid":"11600416","id":"PMC_11600416","title":"NHE3-dependent cytoplasmic alkalinization is triggered by Na(+)-glucose cotransport in intestinal epithelia.","date":"2001","source":"American journal of physiology. Cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/11600416","citation_count":58,"is_preprint":false},{"pmid":"31166707","id":"PMC_31166707","title":"Effect of renal tubule-specific knockdown of the Na+/H+ exchanger NHE3 in Akita diabetic mice.","date":"2019","source":"American journal of physiology. Renal physiology","url":"https://pubmed.ncbi.nlm.nih.gov/31166707","citation_count":58,"is_preprint":false},{"pmid":"11703600","id":"PMC_11703600","title":"Coordinated down-regulation of NBC-1 and NHE-3 in sodium and bicarbonate loading.","date":"2001","source":"Kidney international","url":"https://pubmed.ncbi.nlm.nih.gov/11703600","citation_count":57,"is_preprint":false},{"pmid":"14978207","id":"PMC_14978207","title":"Carbachol regulation of rabbit ileal brush border Na+-H+ exchanger 3 (NHE3) occurs through changes in NHE3 trafficking and complex formation and is Src dependent.","date":"2004","source":"The Journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/14978207","citation_count":56,"is_preprint":false},{"pmid":"12649600","id":"PMC_12649600","title":"Concerted roles of SGK1 and the Na+/H+ exchanger regulatory factor 2 (NHERF2) in regulation of NHE3.","date":"2003","source":"Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/12649600","citation_count":56,"is_preprint":false},{"pmid":"17395628","id":"PMC_17395628","title":"NHE3 inhibition by cAMP and Ca2+ is abolished in PDZ-domain protein PDZK1-deficient murine enterocytes.","date":"2007","source":"The Journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/17395628","citation_count":55,"is_preprint":false},{"pmid":"12081574","id":"PMC_12081574","title":"Na+/H+ exchange activity and NHE-3 expression in renal tubules from the spontaneously hypertensive rat.","date":"2002","source":"Kidney international","url":"https://pubmed.ncbi.nlm.nih.gov/12081574","citation_count":55,"is_preprint":false},{"pmid":"26377793","id":"PMC_26377793","title":"Transcriptional regulation of NHE3 and SGLT1 by the circadian clock protein Per1 in proximal tubule cells.","date":"2015","source":"American journal of physiology. Renal physiology","url":"https://pubmed.ncbi.nlm.nih.gov/26377793","citation_count":55,"is_preprint":false},{"pmid":"15113744","id":"PMC_15113744","title":"NHE3 Na+/H+ exchanger supports proximal tubular protein reabsorption in vivo.","date":"2004","source":"American journal of physiology. Renal physiology","url":"https://pubmed.ncbi.nlm.nih.gov/15113744","citation_count":54,"is_preprint":false},{"pmid":"12081562","id":"PMC_12081562","title":"Role of c-SRC and ERK in acid-induced activation of NHE3.","date":"2002","source":"Kidney international","url":"https://pubmed.ncbi.nlm.nih.gov/12081562","citation_count":54,"is_preprint":false},{"pmid":"8843705","id":"PMC_8843705","title":"Role of tyrosine kinase pathways in ETB receptor activation of NHE3.","date":"1996","source":"The American journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/8843705","citation_count":54,"is_preprint":false},{"pmid":"7494140","id":"PMC_7494140","title":"The mammalian Na+/H+ antiporters NHE-1, NHE-2, and NHE-3 are electroneutral and voltage independent, but can couple to an H+ conductance.","date":"1995","source":"The Journal of general physiology","url":"https://pubmed.ncbi.nlm.nih.gov/7494140","citation_count":53,"is_preprint":false},{"pmid":"10749796","id":"PMC_10749796","title":"Regulation of NHE3 activity by G protein subunits in renal brush-border membranes.","date":"2000","source":"American journal of physiology. Regulatory, integrative and comparative physiology","url":"https://pubmed.ncbi.nlm.nih.gov/10749796","citation_count":53,"is_preprint":false},{"pmid":"9083276","id":"PMC_9083276","title":"Ischemic-reperfusion injury in the kidney: overexpression of colonic H+-K+-ATPase and suppression of NHE-3.","date":"1997","source":"Kidney international","url":"https://pubmed.ncbi.nlm.nih.gov/9083276","citation_count":52,"is_preprint":false},{"pmid":"12181169","id":"PMC_12181169","title":"Upregulation of CFTR expression but not SLC26A3 and SLC9A3 in ulcerative colitis.","date":"2002","source":"American journal of physiology. Gastrointestinal and liver physiology","url":"https://pubmed.ncbi.nlm.nih.gov/12181169","citation_count":49,"is_preprint":false},{"pmid":"25480791","id":"PMC_25480791","title":"Cyclic GMP kinase II (cGKII) inhibits NHE3 by altering its trafficking and phosphorylating NHE3 at three required sites: identification of a multifunctional phosphorylation site.","date":"2014","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25480791","citation_count":48,"is_preprint":false},{"pmid":"19726542","id":"PMC_19726542","title":"AT1 receptor-mediated uptake of angiotensin II and NHE-3 expression in proximal tubule cells through a microtubule-dependent endocytic pathway.","date":"2009","source":"American journal of physiology. Renal physiology","url":"https://pubmed.ncbi.nlm.nih.gov/19726542","citation_count":48,"is_preprint":false},{"pmid":"12464626","id":"PMC_12464626","title":"Transcriptional regulation of the rat NHE3 gene. Functional interactions between GATA-5 and Sp family transcription factors.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12464626","citation_count":48,"is_preprint":false},{"pmid":"21865597","id":"PMC_21865597","title":"Serum- and glucocorticoid-induced kinase 3 in recycling endosomes mediates acute activation of Na+/H+ exchanger NHE3 by glucocorticoids.","date":"2011","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/21865597","citation_count":47,"is_preprint":false},{"pmid":"16543718","id":"PMC_16543718","title":"Aldosterone stimulates activity and surface expression of NHE3 in human primary proximal tubule epithelial cells (RPTEC).","date":"2006","source":"Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/16543718","citation_count":47,"is_preprint":false},{"pmid":"12181191","id":"PMC_12181191","title":"Regulation of NHE3 by nitric oxide in Caco-2 cells.","date":"2002","source":"American journal of physiology. Gastrointestinal and liver physiology","url":"https://pubmed.ncbi.nlm.nih.gov/12181191","citation_count":47,"is_preprint":false},{"pmid":"25925253","id":"PMC_25925253","title":"Caffeine-induced diuresis and natriuresis is independent of renal tubular NHE3.","date":"2015","source":"American journal of physiology. Renal physiology","url":"https://pubmed.ncbi.nlm.nih.gov/25925253","citation_count":46,"is_preprint":false},{"pmid":"19448073","id":"PMC_19448073","title":"Tethering, recycling and activation of the epithelial sodium-proton exchanger, NHE3.","date":"2009","source":"The Journal of experimental biology","url":"https://pubmed.ncbi.nlm.nih.gov/19448073","citation_count":44,"is_preprint":false},{"pmid":"11496061","id":"PMC_11496061","title":"Regulation of the sodium transporters NHE3, NKCC2 and NCC in the kidney.","date":"2001","source":"Current opinion in nephrology and hypertension","url":"https://pubmed.ncbi.nlm.nih.gov/11496061","citation_count":44,"is_preprint":false},{"pmid":"16352745","id":"PMC_16352745","title":"Cardiac glycoside downregulates NHE3 activity and expression in LLC-PK1 cells.","date":"2005","source":"American journal of physiology. Renal physiology","url":"https://pubmed.ncbi.nlm.nih.gov/16352745","citation_count":43,"is_preprint":false},{"pmid":"11557515","id":"PMC_11557515","title":"Regulation of the rat NHE3 gene promoter by sodium butyrate.","date":"2001","source":"American journal of physiology. Gastrointestinal and liver physiology","url":"https://pubmed.ncbi.nlm.nih.gov/11557515","citation_count":43,"is_preprint":false},{"pmid":"18614797","id":"PMC_18614797","title":"Casein kinase 2 binds to the C terminus of Na+/H+ exchanger 3 (NHE3) and stimulates NHE3 basal activity by phosphorylating a separate site in NHE3.","date":"2008","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/18614797","citation_count":43,"is_preprint":false},{"pmid":"26258413","id":"PMC_26258413","title":"Restoration of Na+/H+ exchanger NHE3-containing macrocomplexes ameliorates diabetes-associated fluid loss.","date":"2015","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/26258413","citation_count":42,"is_preprint":false},{"pmid":"22668974","id":"PMC_22668974","title":"Berberine increases the expression of NHE3 and AQP4 in sennosideA-induced diarrhoea model.","date":"2012","source":"Fitoterapia","url":"https://pubmed.ncbi.nlm.nih.gov/22668974","citation_count":41,"is_preprint":false},{"pmid":"11193592","id":"PMC_11193592","title":"Short-term regulation of NHE3 by EGF and protein kinase C but not protein kinase A involves vesicle trafficking in epithelial cells and fibroblasts.","date":"2000","source":"Annals of the New York Academy of Sciences","url":"https://pubmed.ncbi.nlm.nih.gov/11193592","citation_count":41,"is_preprint":false},{"pmid":"27634011","id":"PMC_27634011","title":"Lactobacillus acidophilus counteracts inhibition of NHE3 and DRA expression and alleviates diarrheal phenotype in mice infected with Citrobacter rodentium.","date":"2016","source":"American journal of physiology. Gastrointestinal and liver physiology","url":"https://pubmed.ncbi.nlm.nih.gov/27634011","citation_count":40,"is_preprint":false},{"pmid":"16757729","id":"PMC_16757729","title":"Aldosterone inhibits apical NHE3 and HCO3- absorption via a nongenomic ERK-dependent pathway in medullary thick ascending limb.","date":"2006","source":"American journal of physiology. Renal physiology","url":"https://pubmed.ncbi.nlm.nih.gov/16757729","citation_count":40,"is_preprint":false},{"pmid":"19158399","id":"PMC_19158399","title":"Renal NHE3 and NaPi2 partition into distinct membrane domains.","date":"2009","source":"American journal of physiology. Cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/19158399","citation_count":39,"is_preprint":false},{"pmid":"9886925","id":"PMC_9886925","title":"Thyroid hormone stimulates the renal Na/H exchanger NHE3 by transcriptional activation.","date":"1999","source":"The American journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/9886925","citation_count":39,"is_preprint":false},{"pmid":"20967843","id":"PMC_20967843","title":"Modulatory effect of the SLC9A3 gene on susceptibility to infections and pulmonary function in children with cystic fibrosis.","date":"2010","source":"Pediatric pulmonology","url":"https://pubmed.ncbi.nlm.nih.gov/20967843","citation_count":38,"is_preprint":false},{"pmid":"28384194","id":"PMC_28384194","title":"Loss of SLC9A3 decreases CFTR protein and causes obstructed azoospermia in mice.","date":"2017","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/28384194","citation_count":37,"is_preprint":false},{"pmid":"17882150","id":"PMC_17882150","title":"The acid-activated signaling pathway: starting with Pyk2 and ending with increased NHE3 activity.","date":"2007","source":"Kidney international","url":"https://pubmed.ncbi.nlm.nih.gov/17882150","citation_count":37,"is_preprint":false},{"pmid":"11353667","id":"PMC_11353667","title":"D(1) dopamine receptor regulation of NHE3 during development in spontaneously hypertensive rats.","date":"2001","source":"American journal of physiology. Regulatory, integrative and comparative physiology","url":"https://pubmed.ncbi.nlm.nih.gov/11353667","citation_count":37,"is_preprint":false},{"pmid":"11473625","id":"PMC_11473625","title":"Acute regulation of NHE3 by protein kinase A requires a multiprotein signal complex.","date":"2001","source":"Kidney international","url":"https://pubmed.ncbi.nlm.nih.gov/11473625","citation_count":36,"is_preprint":false},{"pmid":"12167607","id":"PMC_12167607","title":"NHE3 serves as a molecular tool for cAMP-mediated regulation of receptor-mediated endocytosis.","date":"2002","source":"American journal of physiology. Renal physiology","url":"https://pubmed.ncbi.nlm.nih.gov/12167607","citation_count":36,"is_preprint":false},{"pmid":"15265766","id":"PMC_15265766","title":"Gialpha3 protein-coupled dopamine D3 receptor-mediated inhibition of renal NHE3 activity in SHR proximal tubular cells is a PLC-PKC-mediated event.","date":"2004","source":"American journal of physiology. Renal physiology","url":"https://pubmed.ncbi.nlm.nih.gov/15265766","citation_count":36,"is_preprint":false},{"pmid":"18430067","id":"PMC_18430067","title":"The epithelial brush border Na+/H+ exchanger NHE3 associates with the actin cytoskeleton by binding to ezrin directly and via PDZ domain-containing Na+/H+ exchanger regulatory factor (NHERF) proteins.","date":"2008","source":"Clinical and experimental pharmacology & physiology","url":"https://pubmed.ncbi.nlm.nih.gov/18430067","citation_count":35,"is_preprint":false},{"pmid":"28756021","id":"PMC_28756021","title":"Association of clinical severity of cystic fibrosis with variants in the SLC gene family (SLC6A14, SLC26A9, SLC11A1 and SLC9A3).","date":"2017","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/28756021","citation_count":33,"is_preprint":false},{"pmid":"32227118","id":"PMC_32227118","title":"An inducible intestinal epithelial cell-specific NHE3 knockout mouse model mimicking congenital sodium diarrhea.","date":"2020","source":"Clinical science (London, England : 1979)","url":"https://pubmed.ncbi.nlm.nih.gov/32227118","citation_count":33,"is_preprint":false},{"pmid":"18177483","id":"PMC_18177483","title":"Chronic noradrenaline increases renal expression of NHE-3, NBC-1, BSC-1 and aquaporin-2.","date":"2007","source":"Clinical and experimental pharmacology & physiology","url":"https://pubmed.ncbi.nlm.nih.gov/18177483","citation_count":32,"is_preprint":false},{"pmid":"22848392","id":"PMC_22848392","title":"Downregulation of the NHE3-binding PDZ-adaptor protein PDZK1 expression during cytokine-induced inflammation in interleukin-10-deficient mice.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22848392","citation_count":32,"is_preprint":false},{"pmid":"10362780","id":"PMC_10362780","title":"HCO-3 reabsorption in renal collecting duct of NHE-3-deficient mouse: a compensatory response.","date":"1999","source":"The American journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/10362780","citation_count":32,"is_preprint":false},{"pmid":"12684793","id":"PMC_12684793","title":"Aldosterone stimulates surface expression of NHE3 in renal proximal brush borders.","date":"2003","source":"Pflugers Archiv : European journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/12684793","citation_count":31,"is_preprint":false},{"pmid":"17307723","id":"PMC_17307723","title":"Synaptotagmin I binds intestinal epithelial NHE3 and mediates cAMP- and Ca2+-induced endocytosis by recruitment of AP2 and clathrin.","date":"2007","source":"American journal of physiology. Gastrointestinal and liver physiology","url":"https://pubmed.ncbi.nlm.nih.gov/17307723","citation_count":30,"is_preprint":false},{"pmid":"12065291","id":"PMC_12065291","title":"Metabolic acidosis in rats increases intestinal NHE2 and NHE3 expression and function.","date":"2002","source":"American journal of physiology. Gastrointestinal and liver physiology","url":"https://pubmed.ncbi.nlm.nih.gov/12065291","citation_count":29,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":59060,"output_tokens":11627,"usd":0.175792,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":22620,"output_tokens":6448,"usd":0.13715,"stage2_stop_reason":"end_turn"},"total_usd":0.312942,"stage1_batch_id":"msgbatch_013LWZZT6MWaqB9qyTSeQBmU","stage2_batch_id":"msgbatch_0194ZzQaTGNpruoNJBbEMbt3","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1992,\n      \"finding\": \"NHE3 (NHE-3) encodes a Na+/H+ exchanger isoform with 832 amino acids, 10–12 membrane-spanning domains, and a long cytoplasmic tail with putative protein kinase phosphorylation motifs; it is expressed specifically in intestine and kidney.\",\n      \"method\": \"cDNA cloning, sequencing, Northern blot, ribonuclease protection assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — primary cloning and sequencing with direct tissue expression mapping, foundational paper replicated by multiple subsequent studies\",\n      \"pmids\": [\"1374392\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"NHE3 protein localizes to the brush-border (apical) membrane of renal proximal tubule cells, identified as an ~80 kDa polypeptide by isoform-specific antibody on Western blot and immunocytochemistry.\",\n      \"method\": \"Isoform-specific antibody (Western blot, immunocytochemistry), NHE3-transfected cell controls\",\n      \"journal\": \"The American journal of physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal localization confirmed by Western and immunocytochemistry, replicated across multiple subsequent studies\",\n      \"pmids\": [\"8238556\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"NHE3 functions as an electroneutral Na+/H+ exchanger with low amiloride sensitivity, apparent KNa of ~4.7 mM for extracellular Na+, and positive cooperative activation by intracellular H+ (half-maximal pK ~6.45); K+o does not inhibit NHE3 (unlike NHE1).\",\n      \"method\": \"Stable transfection in NHE-deficient CHO (AP-1) cells, amiloride-inhibitable 22Na+ influx assay, kinetic analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro reconstitution with quantitative kinetics, foundational functional characterization replicated by subsequent studies\",\n      \"pmids\": [\"8393860\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"NHE3 is localized to the apical membrane of S1 and S2 proximal convoluted tubules and medullary/cortical thick ascending limbs in rat kidney; cross-linking studies indicate oligomeric forms of the transporter exist.\",\n      \"method\": \"Polyclonal antisera against cytoplasmic epitopes, Western blot of fractionated membranes, immunohistochemistry, chemical cross-linking\",\n      \"journal\": \"Kidney international\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (membrane fractionation, cross-linking, immunohistochemistry), replicated across labs\",\n      \"pmids\": [\"8569082\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"PKA activation acutely inhibits NHE3 activity (~39% inhibition); this requires the cytoplasmic C-terminal domain of NHE3, and the purified recombinant cytoplasmic domain is phosphorylated by PKA catalytic subunit in vitro on serine residues; cAMP increases NHE3 phosphocontent ~3-fold in cells.\",\n      \"method\": \"Stable expression in AP-1 fibroblasts, Xenopus oocyte expression with truncation mutants, in vitro PKA phosphorylation of recombinant domain, immunoprecipitation of phospho-NHE3\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro kinase assay with recombinant domain, truncation mutagenesis, confirmed in two cell systems\",\n      \"pmids\": [\"7593604\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"NHE-1, NHE-2, and NHE-3 are electroneutral and voltage-independent Na+/H+ exchangers; currents observed in some cell types during exchange are due to a pre-existing H+ conductance, not the exchanger itself.\",\n      \"method\": \"Whole-cell patch clamp combined with microfluorimetric pH measurement, CHO cells transfected with NHE isoforms, Zn2+ dissociation experiment\",\n      \"journal\": \"The Journal of general physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — electrophysiology combined with fluorimetry and pharmacological dissection in multiple cell types\",\n      \"pmids\": [\"7494140\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"NHE3 knockout mice (Slc9a3-/-) exhibit reduced HCO3- and fluid absorption in proximal convoluted tubules, a severe intestinal absorptive defect, mild acidosis, reduced blood pressure, and compensatory upregulation of AE1, renin, colonic H+,K+-ATPase, and ENaC; NHE3 is the major absorptive Na+/H+ exchanger in kidney and intestine.\",\n      \"method\": \"Gene targeting/knockout mouse model, blood chemistry, renal tubule perfusion, intestinal flux measurements\",\n      \"journal\": \"Nature genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — loss-of-function mouse with multiple defined physiological readouts, widely replicated\",\n      \"pmids\": [\"9662405\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"E3KARP (NHERF2) directly binds NHE3 at an internal region in its C-terminal cytoplasmic tail via E3KARP's second PDZ domain plus C-terminal domain; E3KARP also binds the cytoskeletal protein ezrin, suggesting a scaffold linking NHE3 to ezrin and thereby to PKA (type II).\",\n      \"method\": \"In vitro binding assays (pulldown), co-localization in PS120 fibroblasts, deletion/domain mapping\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vitro binding with domain mapping plus cellular co-localization, confirmed by multiple orthogonal approaches\",\n      \"pmids\": [\"9748260\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"PI3-kinase activity is required for recycling of intracellular NHE3 to the cell surface; PI3-K inhibitors (wortmannin, LY294002) reduce NHE3 plasma membrane expression by decreasing the rate of recycling of endosomal NHE3, thereby inhibiting NHE3-mediated H+ extrusion.\",\n      \"method\": \"PI3-K inhibitors, epitope-tagged NHE3 in AP-1 cells, immunofluorescence microscopy, ELISA-based surface quantification, temperature-block experiments\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple pharmacological tools, biochemical surface quantification, and temperature controls in a single study\",\n      \"pmids\": [\"9694828\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"cAMP inhibition of NHE3 requires PKA (dominant-negative PKA-regulatory subunit abolishes the effect) and involves in vivo phosphorylation of NHE3 at Ser-552 and Ser-605; single or multiple mutations at these serines reduce PKA regulation, though complex mechanisms involving additional serines also contribute.\",\n      \"method\": \"Dominant-negative PKA expression, site-directed mutagenesis (8 serines mutated), in vitro PKA phosphorylation, tryptic phosphopeptide mapping of in vivo phosphorylated NHE3\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro kinase assay, site-directed mutagenesis, and in vivo phosphopeptide mapping in two cell lines\",\n      \"pmids\": [\"9933588\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"NHERF and E3KARP are necessary for cAMP-dependent phosphorylation of NHE3 in vivo; they act as adapters facilitating PKA-mediated phosphorylation of NHE3, but phosphorylation of NHERF itself is not required for this effect.\",\n      \"method\": \"Co-immunoprecipitation, in vivo phosphorylation assay, dominant-negative NHERF mutant (triple Ser→Ala), 8-Br-cAMP treatment in PS120 fibroblasts\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — co-IP, mutagenesis, and in vivo phosphorylation in the same study, replicated across labs\",\n      \"pmids\": [\"10455146\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"PTH acutely inhibits NHE3 in a biphasic manner: early inhibition (5 min) via NHE3 phosphorylation on multiple serines, followed by dynamin-dependent endocytosis that decreases surface NHE3 antigen (detectable at 30 min); blocking endocytic trafficking with dominant-negative dynamin (K44A) abolishes the late but not early inhibition.\",\n      \"method\": \"Dominant-negative dynamin mutant, surface NHE3 quantification, phosphorylation assay, OKP cell model\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic dominant-negative tool plus biochemical time-course dissecting two distinct inhibitory phases\",\n      \"pmids\": [\"10866993\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"In vivo PTH infusion provokes redistribution of ~25% of NHE3 from apical membranes to intracellular membrane fractions in renal proximal tubule, associated with natriuresis/diuresis; cAMP-PKA signaling is necessary for NHE3 and NaPi2 internalization.\",\n      \"method\": \"Intravenous PTH infusion in rats, sorbitol density gradient fractionation of renal cortex membranes, immunoblotting\",\n      \"journal\": \"The American journal of physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo fractionation with pharmacological controls distinguishing cAMP-dependent from cAMP-independent effects\",\n      \"pmids\": [\"10330053\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"ETB receptor activation increases NHE3 phosphorylation on multiple threonine and serine residues in OKP cells, with ETB but not ETA receptor specificity; phosphorylation correlates temporally with activation of NHE3 activity.\",\n      \"method\": \"Stable transfection of ETB vs ETA receptor cDNA in OKP cells, immunoprecipitation, phosphoamino acid analysis, SDS-PAGE mobility shift, alkaline phosphatase treatment\",\n      \"journal\": \"The American journal of physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — receptor-specific phosphorylation confirmed by alkaline phosphatase reversal and phosphoamino acid analysis\",\n      \"pmids\": [\"10199826\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"G protein subunit Gsα directly associates with and regulates NHE3 in renal brush-border membrane vesicles independently of cytoplasmic second messengers; D1-like receptor-mediated inhibition of NHE3 is partially reversed by anti-Gsα antibodies, and GTPγS increases Gsα co-immunoprecipitation with NHE3; Gβγ dimers appear to have a stimulatory effect on NHE3.\",\n      \"method\": \"Brush-border membrane vesicles devoid of cytoplasmic components, anti-G protein antibodies, co-immunoprecipitation, D1 agonist fenoldopam\",\n      \"journal\": \"American journal of physiology. Regulatory, integrative and comparative physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP with GTP analog plus antibody interference in isolated membrane vesicles, single lab\",\n      \"pmids\": [\"10749796\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"NHERF co-localizes with NHE3 and ezrin specifically in the apical membrane of proximal tubule cells in rat kidney; NHERF2 is absent from proximal tubule but present in collecting duct where it co-localizes with ROMK, indicating isoform-specific compartmentalization.\",\n      \"method\": \"Isoform-specific antibodies, immunocytochemical analysis of rat kidney sections\",\n      \"journal\": \"American journal of physiology. Cell physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct immunolocalization with multiple isoform-specific antibodies, single lab\",\n      \"pmids\": [\"11121391\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Dopamine (DA) acutely decreases surface NHE3 via stimulation of NHE3 endocytosis through clathrin-coated vesicles; this requires GTPase dynamin, involves increased NHE3 binding to adaptor protein AP2, and is dependent on PKA-mediated phosphorylation of NHE3 at Ser-560 and Ser-613.\",\n      \"method\": \"Surface NHE3 antigen quantification, dominant-negative dynamin, AP2 binding assay, PKA inhibition (pharmacological and genetic), Ser→Ala mutations, renal cell line\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple genetic and pharmacological tools, site-directed mutagenesis, AP2 binding assay all in one study\",\n      \"pmids\": [\"11328806\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Ileal brush-border NHE3 exists in three pools: ~50% Triton X-100 soluble, ~50% detergent-insoluble, of which ~33% resides in cholesterol-enriched lipid rafts. EGF and clonidine increase the raft pool of NHE3 in the brush border, associated with increased NHE3 activity; lipid rafts and actin cytoskeleton regulate NHE3 basal endocytosis.\",\n      \"method\": \"Detergent extraction, density gradient fractionation (OptiPrep), EEA1-immunoisolated early endosomes, cholesterol depletion with MβCD, cytochalasin D\",\n      \"journal\": \"The Journal of physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple biochemical fractionation and perturbation approaches in native intestinal tissue and cells\",\n      \"pmids\": [\"11731584\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"NHE3 is activated downstream of SGLT1-mediated Na+-glucose cotransport in intestinal epithelial cells, causing NHE3-dependent cytoplasmic alkalinization that requires p38 MAP kinase activity; p38 MAP kinase activation also occurs with Na+-glucose cotransport and is sufficient to trigger NHE3-dependent alkalinization when activated alone.\",\n      \"method\": \"pH-sensitive dye (BCECF), NHE3-preferential inhibitor S-3226, p38 MAP kinase inhibitors (PD-169316, SB-202190), anisomycin activation, Caco-2 cell monolayers\",\n      \"journal\": \"American journal of physiology. Cell physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pharmacological dissection with isoform-selective inhibitor and kinase inhibitors, reciprocal activation experiment\",\n      \"pmids\": [\"11600416\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Ca2+-dependent inhibition of NHE3 requires E3KARP (not NHERF), and depends on Ca2+-dependent association of α-actinin-4 with E3KARP (via α-actinin-4's actin-binding plus spectrin repeat domain), forming an NHE3–E3KARP–α-actinin-4 complex; elevated Ca2+ causes NHE3 oligomerization and endocytosis, inhibiting activity.\",\n      \"method\": \"PS120 fibroblasts stably expressing E3KARP or NHERF, co-immunoprecipitation, dominant-negative α-actinin-4 fragment, ionomycin treatment, NHE3 activity assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — co-IP with domain mapping, dominant-negative construct, and functional rescue experiments\",\n      \"pmids\": [\"11948184\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"NHE3 supports receptor-mediated, clathrin-dependent endocytosis (RME) in proximal tubule cells by maintaining endosomal pH homeostasis and endocytic fusion; NHE3 confers cAMP sensitivity to RME, and NHE3 deficiency abolishes cAMP effects on endosomal pH and RME.\",\n      \"method\": \"Cellular knockout/retransfection in OKP cells, albumin uptake assay, endosomal pH measurement, cAMP treatment\",\n      \"journal\": \"American journal of physiology. Renal physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — knockout/retransfection rescue design with mechanistic readout (endosomal pH and RME)\",\n      \"pmids\": [\"12167607\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Ezrin phosphorylation at Thr567 is required for NHE3 recruitment to the apical membrane after Na+-glucose cotransport; this occurs downstream of p38 MAP kinase, and a dominant-negative N-terminal ezrin construct blocks NHE3 membrane recruitment and cytoplasmic alkalinization without affecting p38 activation.\",\n      \"method\": \"Dominant-negative ezrin construct, phospho-specific antibody for Thr567, p38 MAP kinase inhibitors, cell surface NHE3 quantification, intestinal epithelial cells\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — dominant-negative genetics, phospho-site antibody, pathway epistasis, multiple orthogonal methods\",\n      \"pmids\": [\"15197272\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Akt2 phosphorylates ezrin at Thr567 in vitro and in cells downstream of PI3-kinase and p38 MAP kinase; Akt2-specific siRNA knockdown prevents ezrin phosphorylation, NHE3 translocation, and NHE3 activation after Na+-glucose cotransport.\",\n      \"method\": \"In vitro Akt kinase assay with recombinant ezrin, Akt2-specific siRNA, PI3-K inhibitors, Akt inhibitors, NHE3 surface translocation assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro reconstitution of Akt2 phosphorylation of ezrin combined with specific siRNA knockdown and functional NHE3 readout\",\n      \"pmids\": [\"15531580\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Carbachol inhibits ileal NHE3 activity by stimulating NHE3 endocytosis from the brush border (detergent-soluble fraction) into early endosomes; carbachol increases the size of NHE3-containing complexes (specifically in detergent-resistant fraction), enhancing co-immunoprecipitation of NHERF2, α-actinin-4, and PKC with NHE3; this inhibition is fully abolished by Src family kinase inhibitor PP2.\",\n      \"method\": \"OptiPrep gradient centrifugation, sucrose gradient centrifugation for complex size, co-immunoprecipitation, surface biotinylation, PP2 Src inhibitor, ileal preparations\",\n      \"journal\": \"The Journal of physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (trafficking, complex formation, co-IP, pharmacological inhibition) in native intestinal tissue\",\n      \"pmids\": [\"14978207\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Glucocorticoid (dexamethasone) activation of NHE3 requires SGK1-mediated phosphorylation of NHE3 at Ser663; in vitro SGK1 kinase assay confirms phosphorylation at Ser663; S663A mutation blocks dexamethasone effect; phosphorylation precedes increased NHE3 activity and is associated with increased surface NHE3 expression.\",\n      \"method\": \"In vitro SGK1 kinase assay, site-directed mutagenesis (S663A), surface biotinylation, pH-sensitive dye NHE3 activity assay\",\n      \"journal\": \"American journal of physiology. Cell physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro kinase assay plus mutagenesis plus surface expression assay identifying a specific phosphorylation site\",\n      \"pmids\": [\"15888551\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"NHERF2 (but not NHERF1) acts as a cGMP-dependent protein kinase G (cGKII) anchoring protein; cGKII must be membrane-anchored via its myristoyl group and bound to NHERF2 to inhibit NHE3; NHERF2 PDZ2 C-terminus binds both NHE3 and cGKII, enabling cGMP inhibition of NHE3.\",\n      \"method\": \"PS120 cell co-expression system, in vitro NHERF-cGKII binding assay, non-myristoylated cGKII mutant, NHE3 activity assay, cAMP/cGMP analog pharmacology\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — in vitro binding with mutational analysis (myristoylation mutant) plus cell-based functional assay\",\n      \"pmids\": [\"15722341\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Glucocorticoids acutely increase surface NHE3 via stimulation of NHE3 exocytosis (insertion), without changes in total NHE3 protein or NHE3 endocytosis; this effect does not require new protein synthesis.\",\n      \"method\": \"Surface biotinylation, biotinylatable NHE3 insertion assay (sulfo-NHS-acetate blockade), MesNa cleavage endocytosis assay, cycloheximide treatment in OKP cells\",\n      \"journal\": \"American journal of physiology. Renal physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal trafficking assays (insertion vs. endocytosis) with protein synthesis inhibitor control\",\n      \"pmids\": [\"15942046\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"EPAC (exchange protein directly activated by cAMP) provides a second, PKA-independent pathway for cAMP inhibition of NHE3 activity; EPAC activation inhibits NHE3 without inducing phosphorylation of NHE3 at serines 552/605 and without redistribution of NHE3 from brush-border membrane.\",\n      \"method\": \"cAMP analogs selective for PKA vs. EPAC, PKA activity assay, H89 inhibitor, NHE3 phosphorylation assay, surface NHE3 quantification in OK cells and murine kidney slices\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — selective pharmacological tools with biochemical read-outs distinguishing two distinct cAMP effector pathways\",\n      \"pmids\": [\"16407144\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"TNF causes NHE3 internalization from the intestinal brush border via PKCα activation, leading to Na+ malabsorption; PKCα inhibition (pharmacological or genetic) prevents NHE3 internalization and diarrhea despite continued barrier dysfunction, demonstrating that coordinated NHE3 inhibition and barrier dysfunction are both required for TNF-mediated diarrhea.\",\n      \"method\": \"In vivo T cell activation mouse model, surface NHE3 quantification, pharmacological and genetic PKCα inhibition, Na+ absorption measurement\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo genetic and pharmacological epistasis with specific molecular and physiological readouts\",\n      \"pmids\": [\"17016558\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Aldosterone inhibits apical NHE3 and HCO3- absorption in the medullary thick ascending limb (MTAL) through a rapid, nongenomic ERK-dependent pathway; aldosterone activates ERK within 5 min, and MEK/ERK inhibitors (U-0126, PD-98059) prevent both ERK activation and NHE3 inhibition; spironolactone and actinomycin D do not block this effect.\",\n      \"method\": \"In vitro perfused rat MTALs, HCO3- flux measurement, ERK immune-complex kinase assay, MEK/ERK inhibitors, spironolactone, actinomycin D\",\n      \"journal\": \"American journal of physiology. Renal physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct tubule perfusion, kinase activity assay, and multiple pharmacological controls distinguishing genomic from nongenomic pathway\",\n      \"pmids\": [\"16757729\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"NHE3 phosphorylation at Ser552 and Ser605 by PKA is dissociated from changes in NHE3 transport activity; dramatic phosphorylation at these sites occurs without altered NHE3 activity in vivo (PTH-infused rats) and precedes transport inhibition in vitro, indicating these phosphorylations do not directly inhibit NHE3.\",\n      \"method\": \"PTH infusion in Sprague-Dawley rats, phosphospecific monoclonal antibodies to pSer552 and pSer605, microvillar membrane vesicle NHE3 activity assay, 22Na uptake in OKP cells\",\n      \"journal\": \"American journal of physiology. Renal physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — phosphospecific antibodies combined with functional transport assay both in vivo and in vitro, single lab\",\n      \"pmids\": [\"17409282\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Synaptotagmin I (Syt I) binds NHE3, co-immunoprecipitates with NHE3 preferentially after cAMP or Ca2+ elevation, and is required for cAMP- and Ca2+-induced NHE3 endocytosis; Syt I siRNA blocks NHE3 endocytosis without preventing NHE3 activity inhibition; Syt I interaction with NHE3 precedes and is required for recruitment of AP2 and clathrin.\",\n      \"method\": \"Co-immunoprecipitation, siRNA of Syt I/AP2/clathrin, 22Na influx, apical membrane biotin labeling, confocal microscopy in Caco-2BBe cells and mouse jejunum\",\n      \"journal\": \"American journal of physiology. Gastrointestinal and liver physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — siRNA knockdown, co-IP, and functional endocytosis/activity assays with multiple components knocked down\",\n      \"pmids\": [\"17307723\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"NHE3's C-terminal domain directly binds ezrin via a positively charged juxtamembrane cluster (K516, R520, R527) interacting with the FERM domain III of ezrin; this direct NHE3–ezrin binding is necessary for basal exocytosis, delivery from synthetic pathway, and brush border movement of NHE3.\",\n      \"method\": \"In vitro binding assays with domain deletions and point mutants, biochemical fractionation, surface NHE3 quantification\",\n      \"journal\": \"Clinical and experimental pharmacology & physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct binding with site mutagenesis, review article citing original data, single lab\",\n      \"pmids\": [\"18430067\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"IRBIT (IP3 receptor-binding protein released with IP3) binds the C-terminal domain of NHE3 and mediates Ca2+-dependent activation of NHE3 via exocytic trafficking to the plasma membrane; this activation requires calmodulin and CaM-dependent kinase II, and IRBIT can reverse NHERF2-dependent Ca2+-inhibition of NHE3.\",\n      \"method\": \"Co-immunoprecipitation, siRNA knockdown of IRBIT, exocytosis assay, calmodulin inhibitor, CaM kinase II inhibitor, NHE3 activity assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — co-IP, siRNA knockdown, pharmacological pathway dissection, and trafficking assay in a single study\",\n      \"pmids\": [\"18829453\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Casein kinase 2 (CK2) binds to the NHE3 C-terminal domain (aa 590–667) and phosphorylates a separate site, Ser719, to stimulate basal NHE3 activity; S719A mutation reduces NHE3 surface expression by decreasing exocytosis and plasma membrane delivery; CK2 inhibitor DMAT inhibits NHE3 carrying S719 but not S719A mutant.\",\n      \"method\": \"LC-MS/MS identification of phosphorylation site, in vitro CK2 kinase assay, S719A/S719D mutagenesis, surface biotinylation, exocytosis assay, CK2 inhibitor DMAT, co-immunoprecipitation\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro kinase assay, mass spectrometry site identification, mutagenesis, surface trafficking assay, and pharmacological confirmation\",\n      \"pmids\": [\"18614797\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"SGK3, localized to recycling endosomes (via its Arg90-dependent PX domain), acutely activates NHE3 within 15 min of glucocorticoid treatment in a PI3K- and PDK1-dependent manner; PDK1 translocates to endosomes upon dexamethasone treatment; mutation of SGK3 Arg90 disrupts endosomal localization and delays NHE3 activation.\",\n      \"method\": \"Transfection of SGK isoforms in PS120 and Caco-2bbe cells, immunofluorescence colocalization, R90A point mutation, PI3K and PDK1 inhibitors, NHE3 activity assay, SGK1/NHERF2 knockout mouse comparison\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple SGK isoforms, point mutagenesis, knockout mouse comparison, subcellular localization with functional consequence\",\n      \"pmids\": [\"21865597\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"cGKII inhibits NHE3 by phosphorylating it at three required sites (rabbit Ser554, Ser607, Ser663; mouse Ser552, Ser605, Ser659); all three phosphorylations must be present simultaneously for cGMP inhibition; cGMP/cGKII reduces surface NHE3. Additionally, Ser663 phosphorylation by dexamethasone is required for glucocorticoid stimulation of NHE3 activity and surface expression.\",\n      \"method\": \"iTRAQ/LC-MS/MS with TiO2 enrichment, phosphospecific antibodies, site-directed mutagenesis, surface biotinylation, NHE3 activity assay in PS120/NHERF2, Caco-2bbe, and mouse ileum\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — mass spectrometry site identification, mutagenesis, phosphospecific antibody validation, multiple cell systems and native tissue\",\n      \"pmids\": [\"25480791\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Loss-of-function SLC9A3 missense mutations (in the N-terminal transport domain and membrane-spanning regions) cause congenital sodium diarrhea; functionally, these mutations reduce NHE3 activity by decreasing basal surface expression and/or abolishing basal transport function of NHE3 in plasma membrane NHE null fibroblasts, while acute regulation remains normal.\",\n      \"method\": \"Whole-exome sequencing, Sanger sequencing, functional expression of mutants in NHE null fibroblasts, Na+/H+ exchange activity assay, surface expression assay\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — human disease mutations functionally validated in cell reconstitution system, multiple independent families\",\n      \"pmids\": [\"26358773\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"NHE3 and scaffold proteins NHERF1, IRBIT, and ezrin form macrocomplexes in the intestinal brush border; in streptozotocin-diabetic mice these macrocomplexes are disrupted, reducing NHE3 activity; insulin restores the macrocomplexes and NHE3 surface expression. IRBIT facilitates NHE3–NHERF1 interaction via protein kinase D2-dependent phosphorylation, and insulin-stimulated ezrin phosphorylation enhances ezrin–NHERF1–IRBIT–NHE3 interactions.\",\n      \"method\": \"Co-immunoprecipitation, diabetic mouse model, insulin treatment, NHERF1/IRBIT siRNA knockdown, NHE3 trafficking assay, PKD2 knockdown\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — co-IP of multiprotein complex, siRNA dissection of components, in vivo diabetic model, and functional NHE3 activity readout\",\n      \"pmids\": [\"26258413\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Tubule-specific NHE3 knockout mice do not respond to empagliflozin (SGLT2 inhibitor) with increased urinary Na+ and bicarbonate excretion or urine pH change, demonstrating that renal NHE3 is required for the natriuretic effect of empagliflozin; empagliflozin in diabetic mice increases NHE3 phosphorylation at S552/S605 (linked to reduced NHE3-mediated reabsorption).\",\n      \"method\": \"Tubule-specific NHE3 knockout mouse (Pax8-Cre), acute empagliflozin dosing, urine electrolyte/pH measurement, phosphospecific NHE3 antibodies\",\n      \"journal\": \"American journal of physiology. Renal physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional knockout with pharmacological challenge providing genetic epistasis, in vivo phosphorylation data\",\n      \"pmids\": [\"32893663\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Inducible intestinal epithelial cell-specific NHE3 knockout mice develop watery alkaline diarrhea, metabolic acidosis, hyponatremia, hyperkalemia, and elevated aldosterone, demonstrating that intestinal NHE3 is essential for Na+, acid-base, and volume homeostasis.\",\n      \"method\": \"Tamoxifen-inducible intestinal epithelial NHE3 knockout (Villin-CreERT2), blood chemistry, urinary and fecal measurements\",\n      \"journal\": \"Clinical science (London, England : 1979)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — tissue-specific conditional knockout with comprehensive metabolic phenotyping\",\n      \"pmids\": [\"32227118\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"ETB receptor (but not ETA) activation increases Na+/H+ antiporter (NHE3) activity in OKP cells via Ca2+/calmodulin kinase pathway (~50%) and tyrosine kinase pathway (~50%); Ca2+ elevation alone (through ETA) is not sufficient for activation.\",\n      \"method\": \"Stable ETB and ETA receptor transfection in OKP cells, BAPTA Ca2+ clamping, KN62 (CaM kinase inhibitor), pertussis toxin, PKC/PLA2/COX inhibitors\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — receptor-specific transfection, multiple pharmacological pathway dissection, Ca2+ clamping\",\n      \"pmids\": [\"8617878\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"ETB receptor-induced NHE3 activation is 50% mediated by tyrosine kinase pathways, involving p210 (integral membrane protein); ET-1 causes tyrosine phosphorylation of focal adhesion proteins (paxillin, p125FAK) via ETB, but these are not required for Na+/H+ antiporter activation.\",\n      \"method\": \"Cytochalasin D disruption of focal adhesions, immunoprecipitation identifying paxillin and p125FAK, tyrosine phosphorylation assay\",\n      \"journal\": \"The American journal of physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — immunoprecipitation identifies specific phosphoproteins; focal adhesion disruption dissects pathway, single lab\",\n      \"pmids\": [\"8843705\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"c-Src and ERK are both required for acid-induced activation of NHE3 in renal proximal tubule cells; dominant-negative c-Src (K295M) prevents NHE3 activation and acidosis activates both c-Src and ERK/MEK (but not JNK) independently; MEK inhibition (PD98059) also blocks NHE3 activation by acid.\",\n      \"method\": \"Dominant-negative c-Src transfection, immune complex kinase assays (enolase, MBP, GST-c-Jun substrates), MEK inhibitor PD98059, in vivo renal cortical kinase activation\",\n      \"journal\": \"Kidney international\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — dominant-negative genetics combined with kinase assays and in vivo pathway confirmation\",\n      \"pmids\": [\"12081562\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"PDZK1 (NHERF3) is required for cAMP- and Ca2+-mediated inhibition of NHE3 in native colonic enterocytes but not for NHE3 abundance, apical targeting, or hyperosmolarity-induced inhibition; pdzk1-/- mice show drastically reduced acid-activated NHE3 activity and abolished responses to forskolin and ionomycin.\",\n      \"method\": \"pdzk1 knockout mice, fluorometric NHE3 activity assay in isolated colonic crypts, Western blot, immunohistochemistry, selective NHE3 inhibitor S1611\",\n      \"journal\": \"The Journal of physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — knockout mouse combined with fluorometric functional assay, selective inhibitor controls, and protein expression analysis\",\n      \"pmids\": [\"17395628\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Loss of SLC9A3 in mice dramatically decreases CFTR protein expression in the epididymis and vas deferens, leading to obstructive azoospermia with abnormal secretions, calcification, and disorganized stereocilia in the male reproductive tract.\",\n      \"method\": \"Slc9a3 knockout mice, immunoblotting of CFTR, immunohistochemistry, ultrastructural analysis (electron microscopy)\",\n      \"journal\": \"PLoS genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — knockout model with multiple orthogonal methods (immunoblot, IHC, EM), clear molecular and structural phenotype\",\n      \"pmids\": [\"28384194\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"SLC9A3/NHE3 is an electroneutral, voltage-independent Na+/H+ antiporter localized to the apical (brush-border) membrane of renal proximal tubule and intestinal epithelial cells, where it mediates the bulk of NaCl, NaHCO3, and fluid absorption; its activity is acutely regulated by dynamic endocytic recycling (controlled by PI3-kinase) and by a multiprotein signaling scaffold—comprising NHERF1/NHERF2 (E3KARP), ezrin, and IRBIT—that anchors PKA, PKG (cGKII), and SGK isoforms in the vicinity of NHE3's cytoplasmic tail, enabling phosphorylation at specific serines (Ser552, Ser605, Ser663, Ser719) to modulate transporter surface expression (exocytosis/endocytosis) and intrinsic activity in response to cAMP, cGMP, Ca2+, glucocorticoids, PTH, dopamine, endothelin, TNF, and other hormones.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"SLC9A3/NHE3 is the principal apical Na+/H+ exchanger of renal proximal tubule and intestinal brush-border epithelia, where it drives the bulk of transepithelial Na+, HCO3-, and fluid absorption [#0, #6, #40]. It operates as an electroneutral, voltage-independent antiporter with low amiloride sensitivity, an extracellular Na+ affinity near 4.7 mM, and cooperative activation by intracellular H+ [#2, #5]. Genetic ablation establishes its physiological centrality: whole-body and tissue-specific knockouts produce defective renal HCO3-/fluid reabsorption, severe intestinal Na+ malabsorption, watery alkaline diarrhea, acidosis, and disturbed volume homeostasis [#6, #40], and loss-of-function missense mutations in its N-terminal transport domain cause congenital sodium diarrhea by reducing basal surface expression and transport [#37]. NHE3 activity is governed by dynamic endocytic recycling, with PI3-kinase required for return of intracellular transporter to the surface and dynamin-/clathrin/AP2-dependent internalization removing it [#8, #11, #16]. This trafficking is organized by a C-terminal scaffold: NHE3 binds directly to ezrin through a juxtamembrane basic cluster and to the PDZ proteins NHERF1/NHERF2(E3KARP) and PDZK1(NHERF3), assembling macrocomplexes that also recruit IRBIT, alpha-actinin-4, and anchored kinases (PKA, cGKII) to position signaling enzymes near the cytoplasmic tail [#7, #19, #25, #32, #38, #44]. Hormonal and metabolic inputs converge on phosphorylation of defined serines that bidirectionally tune surface abundance and intrinsic activity: PKA (Ser552/Ser605), cGKII (multi-site, inhibitory), SGK1 and CK2 (Ser663, Ser719; stimulatory), acting downstream of cAMP, cGMP, glucocorticoids, PTH, dopamine, endothelin, TNF, and Na+-glucose cotransport [#4, #9, #24, #25, #34, #36]. Notably, PKA phosphorylation at Ser552/Ser605 can be dissociated from transport changes, and a PKA-independent EPAC arm also mediates cAMP inhibition [#27, #30].\",\n  \"teleology\": [\n    {\n      \"year\": 1992,\n      \"claim\": \"Establishing that NHE3 is a distinct Na+/H+ exchanger isoform with tissue-restricted expression defined the molecule whose absorptive function the field would dissect.\",\n      \"evidence\": \"cDNA cloning, sequencing, and Northern/RNase protection mapping to intestine and kidney\",\n      \"pmids\": [\"1374392\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Sequence alone did not establish transport kinetics or membrane topology in situ\", \"Subcellular localization not yet defined\"]\n    },\n    {\n      \"year\": 1993,\n      \"claim\": \"Localizing NHE3 to the apical brush-border membrane and characterizing its electroneutral kinetics tied the cloned isoform to vectorial epithelial Na+ absorption.\",\n      \"evidence\": \"Isoform-specific antibody immunocytochemistry/Western blot, and 22Na+ influx kinetics in NHE-deficient CHO cells\",\n      \"pmids\": [\"8238556\", \"8393860\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not address acute hormonal regulation\", \"Oligomeric/quaternary state not resolved\"]\n    },\n    {\n      \"year\": 1995,\n      \"claim\": \"Demonstrating PKA-dependent phosphorylation of the NHE3 C-terminal tail with functional inhibition opened the mechanism of acute hormonal control.\",\n      \"evidence\": \"In vitro PKA phosphorylation of recombinant cytoplasmic domain, truncation mutagenesis in oocytes and fibroblasts\",\n      \"pmids\": [\"7593604\", \"7494140\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific regulatory serines not yet identified\", \"Link between phosphorylation and trafficking unestablished\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Knockout mice and the discovery of PI3-kinase-dependent recycling and NHERF2/ezrin scaffolding showed NHE3 is the dominant absorptive exchanger and is regulated by both trafficking and a C-terminal protein complex.\",\n      \"evidence\": \"Slc9a3-/- mouse physiology, PI3-K inhibitor surface assays, in vitro NHERF2-NHE3-ezrin binding/co-localization\",\n      \"pmids\": [\"9662405\", \"9694828\", \"9748260\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Compensatory upregulation complicated interpretation of basal role\", \"How scaffold links to kinase recruitment not yet mechanistic\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Mapping PKA phosphorylation to Ser552/Ser605 and showing NHERF/E3KARP adapters are required for cAMP-dependent phosphorylation defined the molecular logic of cAMP regulation.\",\n      \"evidence\": \"Site-directed mutagenesis, phosphopeptide mapping, dominant-negative PKA and NHERF in PS120 fibroblasts\",\n      \"pmids\": [\"9933588\", \"10455146\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Additional serines contribute but were not fully resolved\", \"Causal link of these specific sites to transport rate left open\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Dissection of PTH action established a biphasic model: rapid phosphorylation-driven inhibition followed by dynamin-dependent endocytic retrieval of NHE3.\",\n      \"evidence\": \"Dominant-negative dynamin, surface antigen time-course in OKP cells, in vivo PTH infusion with membrane fractionation\",\n      \"pmids\": [\"10866993\", \"10330053\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of early intrinsic-inhibition mechanism not defined\", \"Endocytic adaptor machinery not yet identified\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Direct Gsalpha association with NHE3 in brush-border vesicles indicated regulation that can bypass cytoplasmic second messengers.\",\n      \"evidence\": \"Co-IP with GTPgammaS and anti-G protein antibodies in membrane vesicles, D1 agonist\",\n      \"pmids\": [\"10749796\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab membrane-vesicle co-IP without reciprocal validation\", \"Physiological significance of direct G protein binding unclear\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Defining endocytic and lipid-raft pools and the dopamine/AP2/dynamin internalization pathway connected specific PKA sites to clathrin-mediated retrieval.\",\n      \"evidence\": \"Surface antigen and AP2 binding assays, Ser560/Ser613 mutagenesis, detergent/raft fractionation in renal and intestinal cells\",\n      \"pmids\": [\"11328806\", \"11731584\", \"11121391\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Recognition of NHE3 by endocytic machinery not molecularly defined\", \"Raft-dependence mechanism incompletely resolved\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Identifying the SGLT1->p38 MAPK pathway that activates NHE3 linked nutrient cotransport to coordinate downstream absorptive activation.\",\n      \"evidence\": \"BCECF pH imaging, NHE3-selective inhibitor S-3226, p38 inhibitors and anisomycin in Caco-2 monolayers\",\n      \"pmids\": [\"11600416\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Effector linking p38 to NHE3 membrane recruitment not yet identified\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Showing Ca2+ inhibition requires an E3KARP-alpha-actinin-4 complex and that acid activation requires c-Src/ERK expanded the scaffold and kinase repertoire controlling NHE3.\",\n      \"evidence\": \"Co-IP and dominant-negative alpha-actinin-4 in PS120 cells; dominant-negative c-Src and MEK inhibitors with renal kinase assays\",\n      \"pmids\": [\"11948184\", \"12081562\", \"12167607\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How Ca2+ triggers oligomerization mechanistically unresolved\", \"Direct substrate of c-Src/ERK on NHE3 pathway not defined\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Identifying ezrin Thr567 phosphorylation by Akt2 downstream of p38 as the step recruiting NHE3 to the apical membrane completed the SGLT1-to-trafficking axis.\",\n      \"evidence\": \"Dominant-negative ezrin, phospho-Thr567 antibody, in vitro Akt2 kinase assay and Akt2 siRNA in intestinal cells\",\n      \"pmids\": [\"15197272\", \"15531580\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How phospho-ezrin physically delivers NHE3 to surface not visualized\", \"Generalizability beyond glucose-coupled stimulus untested here\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Resolving distinct stimulatory and inhibitory anchored-kinase modules (SGK1/Ser663 for glucocorticoids; NHERF2-anchored cGKII for cGMP) demonstrated bidirectional, scaffold-localized phosphoregulation.\",\n      \"evidence\": \"In vitro SGK1 kinase assay with S663A mutant and surface assays; cGKII myristoylation/NHERF2 binding mutants in PS120 cells\",\n      \"pmids\": [\"15888551\", \"15722341\", \"15942046\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"cGKII inhibitory phospho-sites not yet all mapped (resolved later)\", \"Crosstalk between stimulatory and inhibitory modules unquantified\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Discovery of a PKA-independent EPAC arm and of TNF-PKCalpha-driven brush-border internalization broadened cAMP signaling and connected NHE3 inhibition to inflammatory diarrhea.\",\n      \"evidence\": \"PKA- vs EPAC-selective cAMP analogs; in vivo T-cell activation model with PKCalpha inhibition; perfused MTAL aldosterone/ERK assays\",\n      \"pmids\": [\"16407144\", \"17016558\", \"16757729\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"EPAC downstream effector on NHE3 not identified\", \"Molecular target of nongenomic aldosterone/ERK on NHE3 unresolved\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Showing Ser552/Ser605 phosphorylation can be dissociated from activity, identifying synaptotagmin I as an endocytic partner, and PDZK1 as an inhibition-specific scaffold refined the relationship between phosphorylation, trafficking, and function.\",\n      \"evidence\": \"Phosphospecific antibodies with transport assays in PTH-rats; Syt I/AP2/clathrin siRNA co-IP in Caco-2/jejunum; pdzk1-/- colonic crypt assays; ETB tyrosine-kinase pathway dissection\",\n      \"pmids\": [\"17409282\", \"17307723\", \"17395628\", \"8843705\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional phospho-site(s) directly controlling transport rate still uncertain\", \"How distinct NHERF isoforms specify different responses unresolved\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Defining the direct NHE3-ezrin binding cluster, the IRBIT-mediated Ca2+/CaMKII exocytic activation, and CK2 phosphorylation of Ser719 detailed the molecular determinants of basal and stimulated surface delivery.\",\n      \"evidence\": \"Point-mutant binding assays (K516/R520/R527-FERM); IRBIT co-IP/siRNA with CaM/CaMKII inhibitors; LC-MS/MS, CK2 assay, S719A/D mutagenesis\",\n      \"pmids\": [\"18430067\", \"18829453\", \"18614797\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of multivalent scaffold assembly not solved\", \"Integration of competing IRBIT-activation vs E3KARP-inhibition unresolved\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Localizing SGK3 to recycling endosomes as a PI3K/PDK1-dependent NHE3 activator added a compartment-specific layer to acute glucocorticoid regulation.\",\n      \"evidence\": \"SGK isoform transfection, PX-domain R90A mutant, PDK1 translocation imaging, knockout mouse comparison\",\n      \"pmids\": [\"21865597\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct SGK3 substrate site on NHE3 not pinpointed\", \"Relative contribution of SGK1 vs SGK3 in vivo unquantified\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Mapping the three obligate cGKII inhibitory sites and confirming Ser663 as the glucocorticoid stimulatory site established multi-site phospho-codes with opposite functional outcomes.\",\n      \"evidence\": \"iTRAQ/TiO2 LC-MS/MS, phosphospecific antibodies, mutagenesis, surface/activity assays in PS120/NHERF2, Caco-2, mouse ileum\",\n      \"pmids\": [\"25480791\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How combinatorial phosphorylation is decoded into trafficking remains mechanistic\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Linking SLC9A3 loss-of-function mutations to congenital sodium diarrhea and showing insulin-restored macrocomplexes in diabetes connected the molecular model to human disease and metabolic state.\",\n      \"evidence\": \"Exome sequencing with mutant reconstitution in NHE-null fibroblasts; diabetic mouse co-IP with NHERF1/IRBIT/PKD2 siRNA\",\n      \"pmids\": [\"26358773\", \"26258413\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Genotype-phenotype severity correlation not fully mapped\", \"In vivo dynamics of macrocomplex assembly not directly observed\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Conditional tissue-specific knockouts proved renal NHE3 is required for SGLT2-inhibitor natriuresis and that intestinal NHE3 is essential for systemic Na+/acid-base/volume homeostasis.\",\n      \"evidence\": \"Pax8-Cre and Villin-CreERT2 NHE3 knockouts, empagliflozin challenge, urine/blood chemistry, phosphospecific antibodies\",\n      \"pmids\": [\"32893663\", \"32227118\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism linking SGLT2 inhibition to NHE3 phosphorylation not fully defined\", \"Reproductive role mechanism (CFTR dependence) addressed separately\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Discovery that NHE3 loss reduces CFTR in the male reproductive tract revealed a non-absorptive role coupling NHE3 to epithelial secretion and fertility.\",\n      \"evidence\": \"Slc9a3 knockout mice, CFTR immunoblot/IHC, electron microscopy of vas deferens/epididymis\",\n      \"pmids\": [\"28384194\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism by which NHE3 controls CFTR abundance unresolved\", \"Direct vs indirect coupling not distinguished\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How combinatorial multi-site phosphorylation, competing scaffold assemblies, and endosomal recycling are integrated in real time to set NHE3 surface density remains the central unresolved mechanistic question.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No structural model of the assembled NHE3-scaffold-kinase macrocomplex\", \"Quantitative decoding of opposing phospho-marks into trafficking outcomes not established\", \"Direct mechanism of NHE3-dependent control of CFTR abundance unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0005215\", \"supporting_discovery_ids\": [0, 2, 5, 6]},\n      {\"term_id\": \"GO:0140104\", \"supporting_discovery_ids\": [2, 5]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [1, 3, 15]},\n      {\"term_id\": \"GO:0031410\", \"supporting_discovery_ids\": [8, 17, 31]},\n      {\"term_id\": \"GO:0005768\", \"supporting_discovery_ids\": [8, 17, 35]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-382551\", \"supporting_discovery_ids\": [2, 6, 40]},\n      {\"term_id\": \"R-HSA-5653656\", \"supporting_discovery_ids\": [8, 11, 16, 31]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [9, 16, 24, 25, 36]}\n    ],\n    \"complexes\": [\n      \"NHE3-NHERF1-IRBIT-ezrin brush-border macrocomplex\",\n      \"NHE3-E3KARP(NHERF2)-alpha-actinin-4 complex\"\n    ],\n    \"partners\": [\n      \"NHERF2\",\n      \"NHERF1\",\n      \"PDZK1\",\n      \"EZR\",\n      \"IRBIT\",\n      \"ACTN4\",\n      \"SYT1\",\n      \"PRKACA\"\n    ],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":7,"faith_pct":100.0}}